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ABSTRACT
This thesis was motivated by the collaborative research undertaken by QMUL and Pfizer UK
into improving experiments at pre-clinical drug development. In theory, the most efficient
designs for these particular experiments, as well as for many other studies, are optimal
designs. Since, however, their implementation poses challenges — and several emerged
during the project — optimal designs are uncommon in practice.
To address these challenges the thesis introduces a comprehensive design framework,
which both generalizes and simplifies optimal design. At the core of this framework are
optimal relaxed designs, seldom considered before. Like a standard design measure a re-
laxed design has non-integer replications and is mathematically tractable; unlike the former,
whose replications must sum to one, it allows the replications total to be unconstrained.
The methodology discussed in this thesis assumes design of experiments for parameter
estimation, given a response model, but also applies to broader problems. Although the
motivation and applications come from the pharmaceutical project, the ultimate goal is to
develop an intuitive and versatile design toolkit for experimenters in various practical fields.
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In experiments, information is ‘bought’, typically from nature, for “money, trouble . . . or
any of innumerable possibilities . . . ” (Savage, 1972, p. 116). The price paid can be high:
for instance, the development of a new drug costs up to two billion dollars and takes up to
fifteen years (PhRMA, 2007; Adams and Brantner, 2006), with the total bill mainly coming
from experimentation. Beside benefiting the pharmaceutical industry, better experiments
could therefore reduce the price of new drugs and the time they take to reach patients, and
make new treatments for rare diseases feasible. Efficient, well-designed experiments could
also benefit research-intensive endeavours beyond pharmaceutics.
The experiments considered in this thesis are traditionally performed using rich designs,
with many observations taken over a dense grid of design points. Alternatively, they could
be performed using optimal designs, described in Fedorov (1972); Silvey (1980); Pukelsheim
(1993); Fedorov and Hackl (1997); and Atkinson, Donev, and Tobias (2007). Such designs
formally exploit pre-experimental information and should — in theory — outperform rich
designs. In practice, despite some recent progress (Berger and Wang, 2005), the former are
far outnumbered by the latter.
This thesis takes on the challenge of making optimal designs viable for more experi-
ments than currently possible. To achieve this aim, optimal design framework is used as the
theoretical basis.
A research project, undertaken by the School of Mathematical Sciences QMUL and
Pfizer Global R&D, Sandwich, UK, in which I participated, serves as a practical inspira-
tion for the methods proposed in the thesis. The project examined applications of optimal
designs to practical drug development, and involved collaboration with statisticians and
pharmaceutical researchers, observation of actual experiments, analyses of experimental
data, and generation and execution of optimally-designed experiments.
The thesis, however, does not present full solutions to these pharmaceutical design ap-
plications, given the enormous complexities involved. Rather, it modifies the existing meth-
ods and develops novel tools that might reduce the gap between the theory and practice of
optimal experimental design. The main assumption behind the proposed methods is that a
parametric response model is known up to the value of its parameter, and a good guess for
the parameter is available.
The thesis contents are as follows. Chapter 2 gives scientific and practical backgrounds
on the pharmaceutical design applications. Chapter 3 builds on standard optimal design
to develop a conceptual foundation for the proposed design approach. Chapter 4 develops
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the necessary technical foundation for optimisation of relaxed designs; generic methods of
constrained differentiable optimisation are employed. Chapter 5 applies the methodology
to specific design problems.
All the numerical design solutions in thesis were found with standard in-built optimisa-
tion procedures in MATLAB 7. The figures are drawn in either MATLAB 7 or JFreeChart,
an open-source graphics library in Java.
2. EXPERIMENTS
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The chapter presents the pharmaceutical studies that motivated the design methodology
in this thesis and states the required statistical assumptions about experiments.
2.1 Drug metabolism
About half of the 200 most-prescribed drugs are metabolised by liver enzymes, members of
the CYP450 family (Rowland and Tozer, 2011, p. 112). A drug metabolised by a particular
enzyme is called a substrate for this enzyme. The enzyme catalyses the substrate’s conver-
sion into a metabolite but itself retains the original form. Table 2.1 in Section 2.3 lists the
main metabolising enzymes and their representative substrates.
Enzyme kinetics investigates rates of enzyme-mediated metabolism. Generally, such
rates, defined in mg/hr or similar units, are functions of time, such as that elapsed since the
drug was administered. These relations are therefore fittingly modelled by differentiable
equations, as reviewed in Appendix B.
The enzyme kinetics studies in this thesis, however, treat time as a nuisance factor:
for instance, metabolic rates are measured at some steady state, during which they remain
approximately constant. Instead, the metabolic rate is modelled as a function of substrate
concentrations, which are assumed constant over the relevant period.
Under the assumption that 100% of some substrate is metabolised by a single enzyme,
the metabolic rate is usually modelled by the Henri-Michaelis-Menten model
v(x) =
V x
K + x
(x ≥ 0), (2.1)
where v(x) is the response, eg in mg/day; x is a substrate concentration; and the constants
V > 0 and K > 0 are the model parameters. The parameter V equals the maximal meta-
bolic rate which is asymptotically approached, in theory, as x → ∞. The parameter K,
called the Michaelis-Menten constant, is the concentration at which the metabolic rate is
half-maximal, ie, v(K) = 0.5V ; see Figure 2.1.
Model (2.1) describes a saturable phenomenon: at small x << K the rate v(x) ≈ VKx
increases almost linearly with x; when x is large relative K, the rate v(x) ≈ V is (almost)
independent from x. This saturation occurs when enzyme becomes increasingly unavailable
for metabolism of greater substrate quantities. (Additional background on (2.1) is given in
Appendix B; see also Segel, 1993 for a detailed discussion.)
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Fig. 2.1: Metabolic rate modelled by (2.1) with K = 5 and V = 500
2.2 Enzyme inhibition
Suppose that one drug is co-administered with another drug, and both metabolised by the
same enzyme. The second drug — the inhibitor — would ‘compete’ for the available en-
zyme, that is, inhibit the enzyme. As a result, the metabolic rate of the substrate could drop
causing substrate accumulation in the body and potential toxicity. Such joint administration
may require extra vigilance or must be avoided altogether.
The substrate metabolic rate in the presence of a competitive inhibitor is described by
the competitive inhibition model
v(x, u) =
V x
K
(
1 +
u
Q
)
+ x
, (2.2)
which assumes model (2.1) for the uninhibited metabolism. The explanatory factors are the
substrate and inhibitor concentrations, with levels x ≥ 0 and u ≥ 0, respectively. The para-
meter θ = (V ,K,Q)T of (2.2) combines the inhibition constant Q > 0 with the parameters
V and K of (2.1), which are independent from the inhibitor (Segel, 1993, Chapter 3). The
response modelled by (2.2) is plotted in Figure 2.2.
The relative activity with and without a competitive inhibitor is
v(x, u)
v(x)
=
K + x
K
(
1 +
u
Q
)
+ x
(x > 0, u ≥ 0), (2.3)
obtained by division of (2.2) by (2.1); see Segel (1993), Chapter 3. In applications, (2.3) is
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appears to shift K to some ‘apparent’ Ka > K while V is unchanged.
often evaluated at fixed x = K, so that
v(K,u)
v(K)
=
2(
1 +
u
Q
)
+ 1
(u ≥ 0). (2.4)
The inhibition strength is characterised by IC50, which is defined, given x = K, as the
concentration u such that v(K,u) is 50% of v(K), with IC50 = 2Q for a competitive
inhibitor. These relations are illustrated in Figure 2.3.
While (2.2) is the most frequently used inhibition model in pharmaceutical applications,
the following inhibition models are also applied: the noncompetitive model
v(x, u) =
V x
(K + x)
(
1 +
u
W
) , (2.5)
where W > 0 is the inhibition parameter; the uncompetitive model
v(x, u) =
V x
K + x
(
1 +
u
P
) , (2.6)
with the inhibition parameter P > 0; and the mixed model
v(x, u) =
V x
K
(
1 +
u
Q
)
+ x
(
1 +
u
P
) , (2.7)
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Fig. 2.3: Percentage ratio (2.4) for a competitive inhibitor with Q = 10; IC50 = 2Q indicated by
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with the inhibition parameters Q > 0 and P > 0. As with (2.2) each of these models is
based on (2.1) for the uninhibited metabolic rate. The mixed model includes the other three
as its special cases: model (2.2) if P → ∞; model (2.6) if Q → ∞; and (2.5) if Q = P .
The Henri-Michaelis-Menten model obtains from (2.7) in the limit P → ∞ and Q → ∞.
Quantities such as IC50 are also used with these models; see Segel (1993).
2.3 Enzyme kinetics studies
Many pharmaceutical compounds, if approved for therapeutic use, could inhibit metabolism
of existing drugs and cause toxicities. Enzyme inhibition studies are therefore a major part
of drug research and development. These studies within pre-clinical drug development
are organised as follows. Each main group of existing drugs metabolised by a particular
enzyme is represented by a substrate from the group; see Table 2.1. The metabolic rate
in each enzyme/substrate (ES) pair is assumed to follow Henri-Michaelis-Menten model
(2.1). If a compound potentially inhibits a particular enzyme, the compound is assessed
in an experiment with the relevant ES pair, and this assessment is generalised to the other
drugs represented by the substrate. The most physiologically relevant enzyme preparation
in such studies is a pooled extract of liver cells from several human donors, which mimics
the average human liver.
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CYP Substrate
1A2 Ethoxyresorufin
2A6 Coumarin
2C8 Paclitaxel
2C9 S-Warfarin
2C19 S-Mephenytoin
2D6 Dextromethorphan
2E1 Chlorzoxazone
3A4 Midazolam
Tab. 2.1: Main representative enzyme/substrate pairs in drug development; adapted from Bjornsson
et al. (2003).
Validation of enzymes
Upon arrival, every new enzyme batch is validated in an experiment with each represent-
ative substrate, without an inhibitor. This validation confirms model (2.1) and estimates
its parameters for each ES pair. Prior estimates of K and V are available from previous
experiments. The validated batch is used in subsequent inhibition studies until it runs out.
The batch may be re-validated at a later time, eg, to ensure that no significant ‘drift’ in its
properties has occurred. As substrate batches are uniform and chemically stable they are
not validated.
Inhibition studies
Enzyme inhibition studies proceed in the following stages.
Stage 0: Initial test without a substrate A compound is assessed for interaction with the
main enzymes (Yuan et al., 2002). If significant interaction with some enzyme(s) is detec-
ted, the compound proceeds to screens with the corresponding ES pair(s).
Stage 1: Inhibition screen The inhibitor is screened with each relevant ES pair at x = K
and at between one and five levels of u. Each screen provides an estimate of IC50, with this
estimate used, eg, to classify the inhibitor as proposed in Obach et al. (2006):
Strong if IC50 ∈ (0, 1];
Medium if IC50 ∈ (1, 10];
Weak or absent if IC50 ∈ (10,∞).
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A decision is made, on a case-by-case basis, whether to continue the development of a
strong inhibitor. Another option is to re-design its molecular structure to reduce the inhibi-
tion potential (Jones et al., 2009).
Stage 2: Detailed studies of inhibition Strong and some medium inhibitors may proceed
to experiments that investigate inhibition models. Designs at this stage are much larger than
those used at the previous stages. All four inhibition models in Section 2.2 can be assumed,
with the experimental objective being to select the most appropriate of these models and
to estimate its parameter. The competitive inhibition model is most likely to be selected.
Parameter estimation at this stage focuses on inhibition parameters, rather than on V and
K. Some functions of θ are also of interest.
A single inhibition model is assumed in some experiments, for instance:
• A validation experiment is performed with a standard inhibitor for quality control of
equipment or for calibration of experimental procedures (Bjornsson et al., 2003).
• The structure-activity relationships (SAR) techniques, which relate the molecular
structure of a compound to its physical properties, imply inhibition mechanisms that
point to a particular model (Jones et al., 2009).
• The inhibition model was established in previous studies with the inhibitor.
• The experimenter is content with assuming the most general model of inhibition, such
as mixed inhibition model (2.7).
2.4 Assumptions about experiments
We use the basic mathematical properties reviewed in Section A.1. The symbols R, R+
and R++ respectively denote all real, nonnegative and positive numbers; Z+ and Z++, the
nonnegative and positive integers. The symbol Rn stands for the n-dimensional Euclidean
vector space; Rn+ and Rn++, for the nonnegative and positive orthants in Rn. The symbol
IN denotes an N ×N identity matrix.
Every explanatory factor for the response is assumed to be quantitative. Any other
factor, which could influence the response, is assumed as fixed. To simplify the notation
we pretend that there is a single factor in the experiment. We now use x to denote a level
of this factor, which needed not be the substrate concentration. Any x belongs to some
X ⊆ R, defined as the region of interest for modelling the response. The explanatory factor
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is also the design factor for the experiment. A design region, X ⊆ X, is selected such
that any x inside X , but not outside it, can be used in the experiment. Some mild technical
requirements to X are given in Section 4.2. A design for an experiment with N ∈ Z++
observations specifies the factor level for taking each observation. For now, a design is
defined as
xN = (x1, x2, . . . , xN )
T (xk ∈ X, k = 1, . . . , N), (2.8)
where each possibly non-distinct design point xk is used for taking one observation.
The response is a scalar quantitative variable whose levels are modelled over X by the
response model η(x,θ). The model includes a parameter vector θ = (θ1, θ2, . . . , θp)T
with some constants θl, where l = 1, . . . , p, which are the individual parameters. Any θ
belongs to some given parameter space Θ ⊆ Rp, whose interior, intΘ, is nonempty. The
function η(x,θ) defines the mapping
η : X×Θ→ R (X ⊆ R, Θ ⊆ Rp), (2.9)
whose rng η ⊆ R and whose domain X includes X. We regard η(x,θ) as purely determ-
inistic, based on some deterministic physical laws that govern the response over X. Some
unique constant θ∗ ∈ intΘ is the true parameter of the model.
The parameter sensitivity vector is the gradient
∂ η(x,θ)
∂ θ
=
[
∂ η(x,θ)
∂ θ1
, . . . ,
∂ η(x,θ)
∂ θp
]T
(θ ∈ intΘ, x ∈ X), (2.10)
whose element l is the partial derivative of η(x,θ) with respect to θl, where l = 1, . . . , p.
We assume that η(x,θ) is differentiable over Θ. The model η(x,θ) is linear in its parameter
if no element of (2.10) depends on any element of θ and nonlinear otherwise (Bates and
Watts (1988), p. 32). The parameter θl of a nonlinear η(x,θ) is conditionally linear if the
element l of (2.10) does not include θl.
For example, the Henri-Michaelis-Menten model
η(x,θ) =
V x
K + x
(
x ∈ X
) (2.11)
is defined with θ = (V ,K)T , Θ ⊆ R2++ and X ⊆ [0,∞). Its X ⊆ X is often defined as
X = [0, xmax], where xmax > 0 is the maximum substrate concentration permitted in the
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experiment. Since
∂ η(x,θ)
∂ θ
=
[
x
K + x
,−
V x
(K + x)2
]T
, (2.12)
the model is nonlinear, with V being its conditionally linear parameter.
Let η(xN ,θ∗) = (η(x1,θ∗), . . . , η(xN ,θ∗))T ∈ RN where each xk belongs to some
xN , for k = 1, . . . , N . The random vector
Y
∣∣η(xN ,θ∗) = (Y1|η(x1,θ∗), . . . , YN |η(xN ,θ∗))T (Y ∈ RN ), (2.13)
has each element Yk distributed conditionally on η(xk,θ∗). Let y = (y1, . . . , yN )T ∈ RN
denote N experimental observations at xN , with yk in y being the observed response at xk.
Assumption 2.1. The observations y at a design xN are a single realisation of a random
variable Y ∈ RN such that
Y
∣∣η(xN ,θ∗) ∼ N (η(xN ,θ∗), σ2IN ) (σ2 > 0), (2.14)
that is, the elements of Y are independently, identically and normally distributed with a
constant variance σ2 > 0. Inferences from y are performed on the basis that (2.14) is
known except for the true parameter θ of the nonlinear η(x,θ). This θ∗ is unique and
belongs to a known intΘ ⊂ Rp.
Equivalently, observations satisfy
y = η(xN ,θ
∗) + e, e ∼ N (0, σ2IN ), (2.15)
where E(y) = η(xN ,θ∗), and e = (e1, . . . , eN )T ∈ RN are the experimental errors.
Assumption 2.1, necessary to focus our discussion of optimal design, is undoubtedly vi-
olated in practice, as the very notions of a ‘known’ model and a ‘true’ parameter are highly
contentious, especially in biology (Burnham and Anderson, 2002, p. 20). Among the phar-
maceutical experiments in the thesis, this assumption is least violated in validation studies,
such as validation of new enzyme batches without an inhibitor, or that of experimental
equipment with a known standard inhibitor.
Given that η(x,θ) is nonlinear, optimal experimental designs depend on θ∗. To simplify
the discussion in the thesis we make
Assumption 2.2. At the stage of experimental design, Assumption 2.1 holds. Also, θ∗ of
2. Experiments 21
the nonlinear η(x,θ) is known.
Since θ∗ need not be known during inference, we consider experiments that ‘confirm’ the
known θ∗ by estimating it from observations. We assume that the whole θ∗ is estimated,
rather than some subsets or functions of θ∗. Clearly, ‘confirmatory experiments’ that satisfy
Assumptions 2.1 and 2.2 cannot occur in practice, but can be simulated on a computer.
2.5 Parametric inference
Let the elements of some vector Y ∈ RN be independently distributed, each with density
πθ∗(Yk), for k = 1, . . . , N , so that
πθ∗(Y ) =
N∏
k=1
πθ∗(Yk), (2.16)
where θ∗ ∈ intΘ is the unknown true parameter, and Θ ∈ Rp. The likelihood function
of the observations y = (y1, . . . , yN )T ∈ RN from πθ∗(Y ) is denoted as l(θ|y) and log-
likelihood, as ln l(θ|y). The maximum likelihood estimator of θ∗ is
θˆ = argmax
Θ
l(θ|y) = argmax
Θ
ln l(θ|y), (2.17)
which must be a global maximiser of l(θ|y) and ln l(θ|y) over Θ.
Suppose ln l(θ|y) is twice-differentiable in a small neighbourhood of θˆ ∈ intΘ. Then,
ln l(θ|y) is expanded near θˆ ∈ intΘ in a Taylor’s series as
ln l(θ|y) ≈ ln l(θˆ|y) +
1
2
(θ − θˆ)T
[
∂2 ln l(θ|y)
∂ (θθT )
]
θˆ
(θ − θˆ), (2.18)
whose last term includes the Hessian matrix of ln l(θ|y). The matrix elements characterise
the steepness of ln l(θ|y) near θˆ, and hence indicate how well θˆ is discriminated from
nearby θ.
The observed information matrix, which stems from Fisher (1925) and Fisher (1934),
is defined as
Mˆ(y) = −
[
∂2 ln l(θ|y)
∂ (θθT )
]
θˆ
, (2.19)
with elements
Mˆi,l(y) = −
[
∂2 ln l(θ|y)
∂ θiθl
]
θˆ
, (2.20)
for i = 1, . . . , p and l = 1, . . . , p. Since θˆ is a maximum, the Hessian matrix in (2.18) is
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negative (semi-)definite, and thus (2.19) is positive (semi-) definite.
The expected information on θ∗ from a future sample from (2.16) is modelled by
ln l(θ|Y ). This information in a small neighbourhood of θ∗ ∈ intΘ is characterised by
the expected information matrix, proposed in Fisher (1925) and Fisher (1934):
M(θ) = −
∫
R
N
[
∂2 ln l(θ|Y )
∂ (θθT )
]
θ
∗
dπθ∗(Y ) (θ ∈ intΘ). (2.21)
This matrix is the expectation, with respect to the true distribution of Y , of the (not-yet) ob-
served information matrix (2.19). Matrix (2.21), crucial to optimal design, is called simply
the information matrix.
We now consider a vector Y ∈ RN that satisfies Assumption 2.1. The log-likelihood of
observations y from this Y is
ln l(θ|y) ∝ −
1
2σ2
N∑
k=1
(yk − η(xk,θ))
2 (θ ∈ intΘ), (2.22)
since σ2 is known. Suppose that θˆ ∈ intΘ, maximising (2.22), exists and that η(x,θ) is
twice continuously differentiable near θˆ. Then (2.20) becomes
Mˆi,l(y) =
1
σ2
N∑
k=1
(
∂ η(xk,θ)
∂ θi
∂ η(xk,θ)
∂ θl
−
(
yk − η(xk,θ)
)∂2 η(xk,θ)
∂ θiθl
)
θˆ
. (2.23)
Element (i, l) of (2.21) evaluated at θˆ is
Mi,l(xN ,θ) =
1
σ2
N∑
k=1
∂ η(xk,θ)
∂ θi
∂ η(xk,θ)
∂ θl
∣∣∣∣
θ
∗
, (2.24)
since Eθ∗(Yk − η(xk,θ)) = 0 for k = 1, . . . , N .
With a linear η(x,θ) the information matrix only depends on xN . Moreover,
N∑
k=1
(
yk − η(xk,θ)
)∂2 η(xk,θ)
∂ θiθl
(2.25)
in (2.23) is zero, and M(xN ) coincides with Mˆ. If η(x,θ) is nonlinear the information
matrix depends on θ, which presents challenges to optimal experimental design. As N →
∞, term (2.25) tends to zero, since ∑Nk=1(yk − η(xk,θ)) → 0 by the strong law of large
numbers. Therefore,
lim
N→∞
Mˆ(Y ) = M(xN ,θ
∗), (2.26)
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that is, Mˆ(Y ) −M(xN ,θ∗) tends to the p× p zero matrix (Bernardo and Smith, 1994,
p. 288). Thus, the information matrix is both the expectation of and an asymptotic approx-
imation to the observed information matrix.
The estimator θˆ provides a point estimate of θ∗ within the maximum likelihood es-
timation; nonlinear least squares; and some Bayesian approaches that assume relatively
noninformative priors on θ; see Bates and Watts (1988); and Seber and Wild (1989). The
following result, stated here informally, characterises θˆ:
Theorem 2.1. Suppose that e ∼ N (0, σ2IN ) where σ2 > 0 is known and let a nonlinear
η(x,θ) be assumed. Given that η(x,θ) is correct and N is large, the maximum likelihood
estimator of θ∗ is approximately
θˆ ∼ N (θ∗,M−1(xN , θˆ)), (2.27)
where M is the information matrix evaluated at θˆ.
This result, rigorously discussed in Seber and Wild (1989), assumes the existence of θˆ ∈
intΘ and some other regularity conditions. A Bayesian interpretation of Proposition 2.1 is
that for large N , the posterior distribution is approximately N (θˆ,M−1(xN , θˆ)); see (Ber-
ger, 1985, p. 224). Given that η(x,θ) and error distribution are correct, θˆ is asymptotically
unbiased, consistent and efficient; Chapter 12 of Seber and Wild (1989) provides the de-
tails. The quality of approximation (2.27) with finite samples depends on xN , η(x,θ) and
other quantities. Some numerical examples in Chapter 6 of Bates and Watts (1988) demon-
strate that this approximation can be poor given some particular η(x,θ). However, in their
example with Henri-Michaelis-Menten model (2.1), this approximation was appropriate.
The following assumption is also made in this thesis:
Assumption 2.3 (Inference). Experimental inference about θ∗ of some nonlinear η(x,θ)
proceeds under Assumption 2.1. The inferential approach estimates θ∗ by the maximum
likelihood estimator θˆ and summarises that the approximation θˆ ∼ N (θ∗,M−1(xN , θˆ))
is valid given any xN with an invertible information matrix.
3. A PLATFORM FOR EXPERIMENTAL DESIGN
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A platform for experimental design is a collection of joined-up tools for designing ex-
periments. Such a platform determines what design problems can be solved and how to
solve them. At the core of the platform in this thesis lies model-oriented optimal design,
which is comprehensively discussed in Fedorov, 1972; Pukelsheim, 1993; Atkinson, Donev,
and Tobias, 2007; and other texts. The proposed platform is presented under the statistical
assumptions given in Chapter 2, including that a nonlinear response model and its true
parameter are known. In a narrow, technical sense, an extreme version of the local design
approach in Chernoff (1953) is implemented, as if we were designing some confirmatory
experiment. A broader goal is to develop a platform that is scalable across a range of exper-
iments.
To find optimal designs we quantify and compare the costs and benefits of candidate
designs. The costs are quantified by explicit cost functions, which appraise the resources
required by designs. One or several cost functions are specified in a design problem. To
quantify the benefits requires a criterion for judging design information matrices accord-
ing to the experimenter’s goals. (The term ‘design optimality criterion’ is eschewed as it
implies design optimality based on information alone, regardless of the costs.) We assume
local criteria for parameter estimation, one or more of which can be specified in a design
problem. A criterion function, defined over information matrices, quantifies the criterion
requirements. The function values are used as a proxy for the benefits of designs, with
smaller values implying more information and greater benefits than larger values do.
Some aspects of experimentation are hard to quantify, for example: experimenter’s in-
tuition; subjects’ inconvenience; the need to visualise the response; the diverse uses of ex-
perimental data by colleagues, regulators and the wider scientific community. There is also
the all-important issue, sidestepped in the thesis, of design robustness to assumptions. Com-
promise designs, incorporated within the design platform, help accommodate these aspects
while maximally preserving statistical information.
The following templates are proposed for optimal and compromise designs:
CRIT Problem: A criterion function is minimised subject to cost constraints.
COST Problem: A cost function is minimised subject to criterion constraints.
LOSS Problem: A loss function, combining a cost function with a criterion function, is
minimised.
MIXED Problem: An objective function is minimised subject to both criterion and cost
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constraints.
Optimal designs are mainly found within CRIT and COST Problems, while MIXED Prob-
lem is mainly used with compromise designs. Design problems are solved over relaxed
designs, whose replications can be any nonnegative number. The requirement of integer
replications is relaxed to enable efficient methods of continuous optimisation. The few ref-
erences found on such designs, including Rafajlowicz (1989); Molchanov and Zuev (2000,
2001); and Sagnol (2011), are reviewed in Section 4.8.
The standard continuous design is the design measure, whose replications must sum to
one. These designs are very useful in conjunction with the proposed approach, as several
problems are most efficiently solved by using, at some stage, design measures. Design
measures allow us to establish equivalences between the two approaches — and hence to
apply a wealth of standard results — but also to pinpoint the differences.
The next section defines relaxed and other designs. Section 3.2 defines the expected
information matrix for the former. Section 3.3 considers criterion functions. Section 3.4
considers linear and nonlinear cost functions. Section 3.5 discusses the four design prob-
lems, with the main emphasis on CRIT Problem and COST Problem. Section 3.6 reviews
standard continuous designs and highlights some areas that could be improved upon with
relaxed designs.
This chapter is about the general, conceptual features of the design platform, whereas
subsequent chapters contain the technical details and design applications.
3.1 Designs defined
We assume that a design region X ⊂ R for some quantitative design factor is given.
Definition 3.1. An exact design over X ⊂ R is
ζ =

x1 x2 . . . xn
z1 z2 . . . zn

 (zj ∈ Z+),
where each distinct xj ∈ X has the integer replication zj for j = 1, . . . , n.
We allow zero replications as well as a null design, with N =
∑n
j=1 zj = 0; hence, there is
the option of ‘no experiment’. Unless null, ζ is equivalent to xN = (x1, . . . , xN )T in (2.8),
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whose xk ∈ X, where k = 1, . . . , N , need not be distinct. For example, in

1.0 20.0
3 2

⇔ (1.0, 1.0, 1.0, 20.0, 20.0)T (3.1)
the same design is stated as ζ on the left and xN on the right.
The notation x = (x1, . . . , xn)T ∈ Xn signifies all the distinct points listed in some
design. The replications in ζ are denoted z = (z1, . . . , zn)T ∈ Zn+. The design support,
denoted supp ζ , comprises every distinct xj having a positive replication.
Since optimisation of exact designs is a hard combinatorial problem, we mainly use the
following designs.
Definition 3.2. A relaxed design over X ⊂ R is
̺ =

x1 x2 . . . xn
r1 r2 . . . rn

 (rj ∈ [0,∞)),
where each xj ∈ X is distinct and has the replication rj for j = 1, . . . , n.
The total N =
∑n
j=1 rj ≥ 0 in ̺ is not constrained by this definition. The replications
r = (r1, . . . , rn)
T ∈ Rn+ in ̺ relax the integer replications z ∈ Zn+ in some ζ . Any ̺ is a
measure such that ̺(x) = 0 for all x /∈ X and ̺(x) ≥ 0 for all x ∈ X ; also ̺(xj) = rj ≥ 0
for every xj in x. As ̺(X) =
∑n
j=1 rj = N ≥ 0, this is not a probability measure.
The set R of all relaxed designs over X is closed under the following operations:
Scalar multiplication (or replication) by κ ≥ 0 produces κ ̺ with each replication κ rj ,
and κN in total.
Addition produces ̺ = ̺a+̺b such that ̺(x) = ̺a(x)+̺b(x) and N = ̺a(X)+̺b(X).
Subtraction produces ̺ = ̺a − ̺b such that ̺(x) = max{0, ̺a(x)− ̺b(x)}.
If R contains ̺a and ̺b, it also contains
̺c = α̺a + β̺b (α ≥ 0, β ≥ 0), (3.2)
and is therefore a convex cone by Definition A.2. Also, R contains all exact designs defined
over X .
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Let ̺∗ denote some optimal relaxed design and r∗, its replications. An exact design can
be obtained from ̺∗ by rounding every non-integer r∗j > 0, with some r∗j ∈ (0, 0.5) possibly
rounded up. Alternatively, integer replications can be optimised over fixed supp ̺∗.
The standard continuous design is the following.
Definition 3.3. A design measure over X ⊂ R is
ω =

x1 x2 . . . xn
w1 w2 . . . wn

 (wj ∈ [0, 1],
n∑
j=1
wj = 1
)
,
where each distinct xj ∈ X has the weight wj for j = 1, . . . , n.
(Note the naming convention: a measure ω is associated with weights w; a relaxed ̺, with
replications r ∈ Rn+; an exact ζ , with z ∈ Z++.)
Definition 3.3 constrains N =
∑n
j=1wj = 1 in any ω, and defines it as a probability
measure, such that ω(X) = 1. Thus, ̺ relaxes the requirement
∑n
j=1 rj = 1. The set, W,
of all design measures over X is a proper subset of R.
Any ̺ with N > 0 can be multiplied by 1/N , that is, normalised, to produce ω = ̺/N
with w = r/N . Conversely, a relaxed design can be ‘unnormalised’ as ̺ = Nω with
r = Nw where N > 0. The notation ̺ ∝ ω signifies that the given ̺ and ω are so related.
3.2 Information matrix
The information matrix of a design is considered under the normal statistical model in As-
sumption 2.1. This matrix of xN has element (i, l) defined in (2.24). By equivalence of xN
and ζ,
Mi,l(xN ,θ) = Mi,l(ζ,θ) =
1
σ2
n∑
j=1
qj
∂ η(xj ,θ)
∂ θi
∂ η(xj ,θ)
∂ θl
, (3.3)
where i = 1, . . . , p and l = 1, . . . , p. We assume that the information matrix is evaluated at
the known θ∗ and omit θ from the notation.
The sensitivity matrix of some x ∈ X is defined as
g(x) =
(
∂ η(x,θ)
∂ θ
)(
∂ η(x,θ)
∂ θ
)T
(θ ∈ intΘ), (3.4)
so that (3.3) implies
M(ζ) =
1
σ2
n∑
j=1
zjg(xj), (3.5)
where zj ∈ Z+.
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Definition 3.4. The information matrix of some ̺ ∈ R is defined under Assumption 2.1 as
M(̺) =
1
σ2
n∑
j=1
rjg(xj) (σ
2 > 0), (3.6)
where rj ≥ 0 is the replication, and g(xj) the sensitivity matrix, of xj ∈ ̺ for j = 1, . . . , n.
As considered in Section 3.5.3, some design solutions depend on σ2, while others do not.
Therefore, σ2 is included into the definition of M(̺), although we often assume σ2 ≡ 1
when possible and convenient.
Let Sp denote the set of all real symmetric p× p matrices; Sp+ ⊂ Sp, of all positive
semidefinite matrices; and Sp++ ⊂ S
p
+, of all positive definite matrices. (Section A.2 reviews
these matrices.) We have M(̺) ∈ Sp+, and possibly M(̺) ∈ Sp++. Let M(R) ⊂ Sp+ be the
set of the information matrices of the designs in R. Given any ̺a and ̺b in R,
M(̺c) = αM(̺a) + βM(̺b) (α ≥ 0, β ≥ 0), (3.7)
where ̺c = α̺a + β̺b and M(̺c) ∈M(R). Therefore, M(R) is a convex cone.
If M(̺) is invertible, M−1(̺) is the expected dispersion matrix of ̺. If M−1(̺) does
not exist then θ cannot be estimated.
Definition 3.5. A design ̺ ∈ R and its M(̺) are nondegenerate if M(̺) ∈ Sp++ and
degenerate otherwise.
Recall that M(̺) is invertible iff M(̺) ∈ Sp++. The set RPD ⊂ R contains all nondegen-
erate designs over X .
Proposition 3.1. Given θ with p parameters, M(̺) ∈ Sp++ iff ̺ contains n ≥ p support
points that admit a set with p linearly-independent vectors ∂ η(xj ,θ)/∂ θ.
Proof Let ̺ be an arbitrary design with N > 0. The proposition holds for ω = ̺/N by
standard results (Pukelsheim, 1993, Chapter 2.8), so that M(̺) = NM(ω) ∈ Sp++. 
Intuitively, a ‘larger’ M(̺a) contains more information than a ‘smaller’ M(̺b) does.
Definition 3.6 (Loewner ordering over Sp). Suppose A and B belong to Sp and let C =
A−B 6= 0. Then,
(i) A ≥ B if C is positive semidefinite;
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(ii) A > B if C is positive definite.
If p > 1, then C can be indefinite, in which case A and B cannot be ranked; see Ex-
ample 3.1.
3.3 Criterion functions
We assume that the experimenter selects a local criterion for estimation of the whole para-
meter θ of some known η(x,θ).
Definition 3.7. The criterion function Ψ : Sp++ → R computes a scalar summary of M(̺)
according to the chosen criterion and has the following properties:
(i) Ψ(M(̺a)) < Ψ(M(̺b)) implies that ̺a ∈ RPD is more informative than ̺b ∈ RPD.
(ii) Ψ(M(̺)) is decreasing: for any A and B in Sp++, the inequality A ≥ B implies
Ψ(A) ≤ Ψ(B); and A > B implies Ψ(A) < Ψ(B).
(iii) rngΨ = (α,∞) where α ∈ [−∞,∞).
The function Ψ
(
M(̺)
)
is defined over Sp++ to circumvent technical difficulties (described
in Silvey, 1980, Chapter 3) and prevent degenerate designs. Throughout, we assume M(̺) ∈
S
p
++. Property (i) means that smaller values of Ψ
(
M(̺)
)
imply more information than
greater values do. Property (ii) preserves the matrix ordering in Definition 3.6; property
(iii) is justified in Chapter 4. Every specific Ψ(M(̺)) considered next satisfies Definition
3.7 and has rngΨ = (0,∞).
If p = 1 we simply summarise uncertainty about θ∗ by the dispersion matrix, so that
Ψ
(
M(̺)
)
= M−1(̺). (3.8)
The A-criterion is ‘to summarise uncertainty about θ∗ by the sum of the expected variances
of parameter estimates’, so that
Ψ
(
M(̺)
)
= trM−1(̺) =
p∑
l=1
var (̺, θl). (3.9)
The D-criterion is ‘to summarise uncertainty about θ∗ by the determinant of the dispersion
matrix’, so that
Ψ
(
M(̺)
)
= |M−1(̺)| = |M(̺)|−1. (3.10)
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We have that
trM−1 =
p∑
l=1
1
El
, |M−1| =
p∏
l=1
1
El
, (3.11)
where El > 0 is a possibly non-distinct eigenvalue of M(̺). (The nonstandard notation El
avoids clashing with some later notation.)
Following Atkinson et al. (2007, p. 60) we define the confidence region
{
θ ∈ Rp : (θ − θ∗)TM(̺,θ∗)(θ − θ∗) ≤ 1
}
(M(̺) ∈ Sp++), (3.12)
centred at θ∗; see Figure 3.1. The half-length of some axis of the ellipsoid is
dl =
√
1
El
> 0 (l = 1, . . . , p), (3.13)
so that the A-criterion function satisfies
trM−1 =
p∑
l=1
d2l , (3.14)
and the D-criterion function,
|M−1| =
p∏
l=1
d2l ∝ V
2, (3.15)
where V is the ellipsoid volume (Hannah, 1996).
Example 3.1 (CYP2C19/S-Mephenytoin: confirmatory experiment).
We consider design of an enzyme kinetics study with the Henri-Michaelis-Menten model
η(x,θ) =
V x
K + x
(
x ∈ X
)
, (3.16)
which will be denoted as ηHM for brevity. Various optimal designs for ηHM were con-
sidered in many references, including Duggleby (1979); Currie (1982); Bates and Watts
(1988); Dette and Wong (1999); Lopez-Fidalgo and Wong (2002); Murphy et al. (2003);
Dette and Biedermann (2003); Matthews and Allcock (2004); and Dette et al. (2008).
We assume experimentation with CYP2C19/S-Mephenytoin, which is a common en-
zyme/substrate pair used in pharmaceutical research; as discussed in Chapter 2. The exper-
iment seeks to confirm some known θ∗ by estimating in from observations. The specific
details of this experiment are modelled after an enzyme kinetics study, with CYP2C19
and S-Mephenytoin, that was reported in Di-Marco et al. (2007). We assume the same
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X = [0, 500] and select (V ∗,K∗) = (1, 35)T , where K∗ is set to Kˆ reported in Di-Marco
et al. (2007) and V ∗ to a notional value. The normal statistical model in Assumption 2.1 is
assumed with σ2 = 1.
The assumed standard design,
rich =

2.5 5 7.5 17.5 25 50 75 125 250 500
2 2 2 2 2 2 2 2 2 2

 , (3.17)
with n = 10 and N = 20, is based on the actual design in Di-Marco et al. (2007). The
support points in (3.17) were visually approximated from Figure 5 of that paper. As typical
in enzyme kinetics (Segel, 1993, p. 46; Currie, 1982; Lopez-Fidalgo and Wong, 2002;
and Galetin et al., 2005) this design has equally replicated points, mostly at low substrate
concentrations, “with a few sprinkled at higher concentrations” (Currie, 1982).
We now investigate designs under the A- and D- criteria. To facilitate comparisons with
(3.17) we fix N = 20 for the other designs. The design ̺A minimising (3.9) was found with
an optimal design tool at http://optimal-design.biostat.ucla.edu. The design ̺D minimising
(3.10) is 20 replications of
ω =

K/(1 + 2K/xmax) xmax
1/2 1/2

 , (3.18)
which is the ‘local D-optimal’ design measure for ηHM ; see Matthews and Allcock (2004);
and Dette, Kiss, and Wong (2008). Table 3.1 lists the three designs, and Figure 3.1 plots the
corresponding ellipses (3.12). Since the ellipse for rich fully covers the other ellipses,
this design is the least informative among the three: indeed, M(rich) < M(̺A) and
M(rich) < M(̺D) by Definition 3.6. The ellipses corresponding to ̺A and ̺D overlap,
even if rotated about θ∗, and thus M(̺A) and M(̺D) are only comparable with respect to
some criterion. 
Although the A-criterion is intuitive and common in practice (Bailey, 2007) its use with
nonlinear η(x,θ) is limited: optimal designs depend on the measurement scale of θ and of
the design factors, and on how η(x,θ) is parameterised (Mead, Gilmour, and Mead, 2012,
Chapter 16.4). The D-criterion entails no such dependencies and is standard in nonlinear
optimal design (Atkinson et al., 2007). We consider both, but mainly the latter.
Suppose that m ≥ 2 criteria are specified in a design problem. A compound criterion
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trM−1 |M−1|
̺A
[
22.11 500
14.14 5.86
]
2728 377
̺D
[
30.70 500
10 10
]
3212 294
rich
[
2.5 5 . . . 500
2 2 . . . 2
]
5563 818
Tab. 3.1: Designs for Example 3.1.
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Fig. 3.1: Ellipsoids (3.12) in Example 3.1: for rich in ( ); ̺A in ( ); ̺D in ( ). Ellipsoidal
half-axes for ̺D shown in ( ); the value θ∗ in (•)
function can then be defined as
Ψ
(
M(̺)
)
=
m∑
i=1
hiΨi
(
M(̺)
)
(hi > 0), (3.19)
where Ψi
(
M(̺)
)
is the function, and hi the ‘importance’ coefficient, for criterion i. With
two criteria we could set h1 = 1 and h2 = h, as in
Ψ
(
M(̺)
)
= |M−1(̺)|+ h trM−1(̺) (h > 0), (3.20)
given the D-criterion and A-criterion. The experimenter could also specify m, or fewer,
criterion constraints Ψi
(
M(̺)
)
≤ ci where the targets are ci ∈ rngΨi for i = 1, . . . ,m.
Any Ψi
(
M(̺)
)
could simultaneously enter a design problem within a criterion constraint
and within (3.19).
3.4 Cost functions
Definition 3.8. The cost function φ : R → R computes the total cost of an experiment
according to ̺. This φ(̺) satisfies:
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(i) rng φ = [0,∞);
(ii) φ(̺) = 0 iff ̺ is null;
(iii) adding replication at any xj increases φ(̺).
Naturally, φ(̺a) < φ(̺b) implies that ̺a is cheaper than ̺b.
As the approach in Chapter 4 fixes design points, the only variable in φ(̺) is the replic-
ations r ∈ Rn+. We assume that one observation at a given xj costs some known constant
γj > 0, where j = 1, . . . , n. The linear cost is
φ(̺) =
n∑
j=1
γjrj = γ
Tr (γ ∈ Rn++), (3.21)
which satisfies
φ(κ ̺) = κφ(̺) (κ ≥ 0). (3.22)
The fixed cost is a special case of (3.21) such that
φ(̺) =
n∑
j=1
rj = 1
Tr = N, (3.23)
which implies γj = 1 for all j.
Suppose that the experiment requires q ≥ 2 distinct resources.
Definition 3.9. The cost φk : R → R computes the quantity of resource k required by ̺,
where k = 1, . . . , q. This φk(̺) satisfies rng φk = [0,∞) and φk(̺) = 0 iff no resource k
is used by ̺.
If q = 1 then φ1(̺) is just the total cost φ(̺) in Definition 3.8. If q ≥ 2 then φk(̺) = 0 is
possible for some nonnull designs.
To accommodate distinct resources, we could define φ(̺) as a compound cost
φ(̺) =
q∑
k=1
vkφk(̺) (vk > 0), (3.24)
where vk is the (relative) price of resource k. If each vk is in £ per unit of resource k then
all these q resources can be merged into a single ‘money’ resource. Also, any φk(̺) can
itself be compound. With disparate resources — experimenters’ pay vs. subjects’ patience
— each vk must be elicited.
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Fig. 3.2: A 12 × 4 reaction block. The enzyme amount (•) is fixed per well; the substrate amount
(•) varies with xj .
We could also put (some of) the functions φk(̺) into cost constraints φk(̺) ≤ Bk,
where Bk > 0 is the available quantity of resource k. Any φk(̺) can simultaneously enter
a design problem within (3.24) and within a cost constraint.
Example 3.2 (CYP2C19/S-Mephenytoin, continued).
Observations in this experiment require individual wells inserted into a reaction block;
see Figure 3.2. Design (3.17) specifies n = 10 substrate concentrations xj , each with
rj = 2, and requires N = 20 wells. The enzyme amount is fixed per well; the substrate
amount is set according to xj .
For the moment, we ignore the reaction block and assume that the remaining resources
are purchased before the experiment and not reused after. Hence, we define
φ(̺) =
n∑
j=1
(v1 + v2xj)rj = v11
Tr + v2x
Tr (v1 > 0, v2 > 0,x ∈ R
n
+), (3.25)
where v1 is the fixed cost per observation, and v2 the cost per unit of x. By setting γj =
v1 + v2xj in (3.25) we obtain linear cost (3.21).
Suppose that the reaction block, with NS = 48 slots, must be bought for v0 > 0. Any
̺ with N ∈ (0, 48] costs v0; any with N ∈ (48, 96] costs 2v0; and so on. Since this cost is
lumped, a continuous relaxation of NS may not work, unless v0 is small. Usually, reaction
blocks are reused but their availability is limited. With only one block available, there is the
constraint 1Tr ≤ NS on any ̺. Likewise, if only A > 0 of the substrate is available, there
is the constraint xTr ≤ A. 
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To the best of my knowledge, continuous designs have not been optimised under costs
nonlinear in replications. As illustrated next, such costs could occur in experiments.
Example 3.3 (Clinical trial).
In this hypothetical trial, the therapeutic response to some drug is investigated in a pop-
ulation of unhospitalised patients. The drug also causes unpleasant but not life-threatening
toxicity. The therapeutic response is described by
η(x,θ) =
Eνx
Dν + xν
(x > 0), (3.26)
where x is the dose and θ = (E,D, ν)T ∈ R3++. (This is a variant of the Emax model,
common in such studies; MacDougall, 2006). The therapeutic and toxic responses to the
drug are illustrated in Figure 3.3.
The trial subjects are split into n groups. Those in group j receive the same dose xj > 0
throughout the trial, lasting T weeks. At the end of each week, the subjects visit the trial
clinic, where the therapeutic response is observed, with the last observation taken at T .
As usual in clinical trials, some subjects drop out “through boredom, adverse reactions”
and for other reasons (Bailey, 2008, p. 118). We assume that the probability of a subject’s
dropping out depends on the individual’s therapeutic and adverse responses, and thus on the
dose. Let the probability that a subject from group j drops out during [0, t] ⊆ [0, T ] follow
the Weibull distribution (common in survival analysis) with CDF
Fj(t) = 1− exp
(
−(t/βj)
αj
)
(t ≥ 0, j = 1, . . . , n), (3.27)
where t is the end-point of [0, t]. The distribution parameters, βj > 0 and αj > 0, are the
same for group j but differ between groups.
Suppose T = 6 weeks, and n = 3 groups are allocated x1 = 3, x2 = 30 and x3 = 100,
respectively. The pattern of dropouts in Figure 3.3 is explained as follows. Many subjects
in the ‘low-dose’ group had little benefit, stopped the therapy and dropped out early. The
remaining subjects in the group had a satisfactory effect and were likely to stay on after
week 2. Dropouts in the ‘high-dose’ group rapidly increased from week 3 when subjects
started to experience toxicity. The subjects in the ‘medium-dose’ group received the greatest
benefit and were the least likely to drop out.
Subjects’ dropouts are costly, as more subjects are ultimately required for the trial. Let
the trial in group j with Nj ∈ Z++ subjects last Tj weeks, and γj > 0 be the cost of a
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Fig. 3.3: (L) Efficacy ( ); toxicity ( ). (R) Weibull CDF for drop-out during [0, t] for dosing
groups: low (•), medium (•), high (•).
subject’s drop-out before Tj . Since observations are taken at the end of each week, per-
subject replication is rj = Tj . Given the Weibull distribution (3.27), the expected cost due
to dropout is
n∑
j=1
γjNj(1− exp
(
−(rj/βj)
αj
)
(γj > 0) (3.28)
for the experiment. That cost is nonlinear in each rj can influence the doses, group sizes
and other aspects of optimal designs. (Such designs are more general than ̺ and are not
considered in this thesis. Moreover, (3.28) does not satisfy the assumptions in Chapter 4.)

Nonlinear costs may occur if each replication takes appreciable time and space; human
subjects and experimenters are burdened; delicate devices are used; the capacity of some
equipment is limited; and several studies proceed concurrently. More specifically:
• Each additional blood sample from a patient increasingly causes inconvenience, phys-
ical discomfort and ethical cost.
• Extra replications divert the trial staff from their medical duties.
• The experimenter makes more mistakes towards the end of a day-long experiment.
• Delicate equipment is used under extreme physical conditions. As studied within the
field of reliability (Gnedenko and Ushakov, 1995; Kotz et al., 2003) the probabil-
ity of equipment failure grows nonlinearly with time and load, and often follows a
Weibull CDF. Such failure can be a major break-down or more subtle, eg, decreased
measurement precision and increased likelihood of outliers.
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• Reaction wells from an enzyme study are processed by the spectrometer, one well at
a time. More samples make the spectrometer less available for other studies.
• Long-term experiments with plants are performed in a greenhouse. Each replication
requires a pot with a plant. More replications leave less room for pots from other
experiments and indeed for experimenters’ access (Bailey, 2014). Stacking too many
heavy pots might also cause material or structural damage.
• Experimenters compete with colleagues for workbench space (Bailey, 2008, p. 6).
Extra samples delay other experimenters’ studies.
As just illustrated, the variety and complexity of real-life experimentation and of its costs
are vast. Unless principal costs and resource requirements are provided for, at least approx-
imately, an ‘optimal’ design is not optimal in the economic sense. Therefore, nonlinear
φ(̺) and other methods to bring realistic costs within the remit of optimal design could
have practical merit.
A difficulty with nonlinear costs is that they can be intangible and hard to quantify. If
their impact is large, and prior information is available, sophisticated modelling of costs is
justified. (For instance, the queueing theory could be used to model the costs due to time
delays when concurrent experiments send their samples for spectrometry. ) Sometimes a
rough approximation, with a simple nonlinear φ(̺), could markedly improve designs.
A simple nonlinear φ(̺) is the quadratic cost
φ(̺) = γTr + v(1Tr)2 = γTr + vN2 (v > 0, γ ∈ Rn+), (3.29)
which augments (3.21) by the penalty term vN2, where v is a scaling constant. (This φ(̺)
is compound cost (3.24) in which v1 = 1 and v2 = v are set.) Any γj = 0 is allowed, since
each rj is already penalised by vN2. This cost could be used to accommodate capacity
constraints, eg, on the spectrometer time. Although simple, this φ(̺) highlights some key
features of optimal designs under nonlinear costs. The penalty functions in Chapter 5 are
extensions of (3.29).
Compared to a linear cost, a nonlinear φ(̺) could have technical advantages, eg, in
continuous approximation to integer costs of reaction blocks and indeed of exact designs.
Another potential advantage is illustrated in Example 3.5 later in the chapter.
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3.5 Design problems
The following discussion assumes that criterion functions and cost functions do not contra-
dict the conditions given in sections 4.3 and 4.4, respectively. This assumption holds with
every Ψ
(
M(̺)
)
and φ(̺) in this chapter, except for (3.28).
3.5.1 CRIT Problem
The experimenter specifies a criterion function Ψ
(
M(̺)
)
, a cost function φ(̺) and a total
budget B for the experiment.
Problem 3.1 (CRIT).
minimize
RPD
Ψ
(
M(̺)
) (3.30a)
subject to φ(̺) ≤ B, (3.30b)
where B > 0.
The objective function Ψ(M(̺)) is minimised subject to a cost constraint, which en-
sures that no experiment costs more thanB. A solution ̺∗ is a global minimiser of Ψ
(
M(̺)
)
among the nondegenerate designs that satisfy (3.30b). As proven in Chapter 4, a solution
exists and attains φ(̺∗) = B. Thus, the motto is ‘Spend the whole budget and gain max-
imum information.’
Problem 3.1 is closely related to standard optimal design over design measures (Elfving,
1952; Fedorov and Hackl, 1997, p. 57).
3.5.2 COST Problem
The experimenter specifies a cost function φ(̺), a criterion function Ψ
(
M(̺)
)
and a cri-
terion target as some c ∈ rngΨ corresponding to the maximum acceptable uncertainty.
Since rngΨ is an open interval, Ψ
(
M(̺)
)
> c for some nondegenerate designs and
Ψ
(
M(̺)
)
≤ c for others. Therefore, any c ∈ rngΨ is neither trivial nor unattainable
with any design.
Problem 3.2 (COST).
minimize
RPD
φ(̺) (3.31a)
subject to Ψ
(
M(̺)
)
≤ c, (3.31b)
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where c ∈ rngΨ.
The objective φ(̺) is minimised subject to a criterion constraint. A solution ̺∗ is a global
minimiser of φ(̺) over all ̺ ∈ RPD that satisfy (3.31b). A solution ̺∗ exists and satisfies
Ψ
(
M(̺∗)
)
= c. Thus, the motto is ‘Collect the minimally required information, at the least
cost’.
This problem has not been widely considered in optimal design. For instance, Tuch-
scherer (1983) only stated a similar problem over design measures, without pursuing it
further. Fedorov (1972), p. 61, briefly discussed minimisation of an integer N in a design
subject to an “accuracy” constraint. COST approach has been used in other types of exper-
imental design. An example is sample size problems (Raiffa and Schlaifer, 1961), in which
a non-integer N could be allowed (Bailey, 2008, Chapter 2.13).
3.5.3 Equivalence
Two optimisation problems are equivalent if a solution to one is readily obtained from that
to the other (Boyd and Vandenberghe, 2004, p. 130). Such equivalence helps simplify
optimisation and extend formal results to different problems. Basic equivalence holds if
one problem is a scaled version of another. Therefore, the objective and any constraint in a
problem can be multiplied by some κ > 0without affecting solutions. For instance, whether
both sides of φ(̺) ≤ B in CRIT Problem are defined in sterling, pounds or kilograms is
irrelevant to optimisation.
Instances of a design problem are assumed to have identical specifications except for
those stated explicitly.
Proposition 3.2 (CRIT instances). Let Instance A of Problem 3.1 be defined with Ba and
σ2a; and Instance B with Bb and σ2b . Suppose Instance A is solved by ̺∗, with ω∗ ∝ ̺∗, and
let κ > 0. Then Instance B is solved by
(i) κω∗ if φ(̺) = γTr where γ ∈ Rn++;
(ii) κω∗ if φ(̺) = γ1Tr + vN2 where v > 0 and γ ≥ 0;
(iii) ̺∗ if Bb = Ba.
Proposition 3.3 (COST instances). Let Instance A of Problem 3.2 be defined with ca and
σ2a; and Instance B with cb and σ2b . Suppose Instance A is solved by ̺∗, with ω∗ ∝ ̺∗, and
let κ > 0. Then Instance B is solved by
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(i) κω∗ if φ(̺) = γTr where γ ∈ Rn++;
(ii) κω∗ if φ(̺) = γ1Tr + vN2 where v > 0 and γ ≥ 0.
Part (iii) of Proposition 3.2 implies, given any φ(̺), that a CRIT solution is independent
from σ2, which is not generally the case with COST solutions.
Equivalence over ω∗ simplifies design optimisation, as κ in κω∗ is easier to find than
̺∗ from scratch. This equivalence also means that optimal relaxed designs are equivalent
to standard optimal design measures. Results and numerical methods developed for either
approach are then applicable. However, equivalence over ω does not generally hold if φ(̺)
is nonlinear; eg, φ(̺) = γTr + vN2 where v > 0 and some of the n ≥ 2 elements
of γ ∈ Rn++ are distinct. In such cases, standard methods over design measures are not
immediately applicable.
Proposition 3.4 (CRIT and COST Problems). If ̺∗ solves
minΨ
(
M(̺)
)
s. t. φ(̺) ≤ B, (3.32)
and attains Ψ
(
M(̺∗)
)
= c then ̺∗ also solves
minφ(̺) s. t. Ψ
(
M(̺)
)
≤ c, (3.33)
and attains φ(̺∗) = B. The converse is also true.
This result is shown in Chapter 4 for any cost function characterised in 4.4. (A similar result
over ω is suggested, without a proof, in Tuchscherer (1983).) If φ(̺) admits equivalence
of design measures, then Proposition 3.4 allows us to solve a CRIT problem via a COST
problem and vice versa.
Example 3.4 (CYP2C19/S-Mephenytoin, continued). DATA : ηHM ; (V ∗,K∗) = (1, 35);
σ2 = 1; X = [0, 500]; rich in (3.17).
We assume the D-criterion function Ψ
(
M(̺)
)
= |M(̺)|−1 and linear cost (3.25).
Analytical solutions for this design problem, with ηHM , were proposed in Volkov et al.
(2008). Optimality of the designs in this example can be verified as discussed in Chapter 4.
(Table 3.2 gives the designs and related quantities with a higher precision than that in the
text.)
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Fig. 3.4: Equivalence of CRIT and COST problems under φ(̺) in (3.34). Design (3.35) shown in
(•). Criterion function is Ψ(M(̺)) = |M(r1, r2)|−1. Objective contours ( ) improve
as (−→); every (r1, r2) within ( ) is feasible.
Empirical costs Specifically, let
φ(̺) = 1.471Tr + 0.0441xTr, (3.34)
defined in pounds sterling; see Section B.2 for an empirical justification. COST Problem
3.2 with this φ(̺) and Ψ
(
M(̺)
)
≤ 818 = Ψ
(
M(rich)
)
is solved by
̺∗ =

19.1 188.9
17.3 4.1

 , (3.35)
with φ(̺∗) = £80 and Ψ
(
M(̺∗)
)
= 818. The same ̺∗ solves a CRIT problem subject
to φ(̺) ≤ 80 and attains Ψ
(
M(̺∗)
)
= 818; see Figure 3.4. A CRIT problem subject to
φ(̺) ≤ 123 = φ(rich) is solved by
̺∗ =

19.1 188.9
26.5 6.3

 , (3.36)
which attains Ψ
(
M(̺∗)
)
= 346 and φ(̺∗) = 123. Both (3.35) and (3.36) normalise to
ω∗ =

19.1 188.9
0.81 0.19

 , (3.37)
as expected from Propositions 3.2 and 3.3.
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N design measure cost, £ Ψ
(
M(̺)
)
design
20
[
2.50 . . . 500.0
0.10 . . . 0.10
]
122.67 818.0154 rich (3.17)
21.3133
[
19.0802 188.8964
0.8092 0.1908
]
79.73 818.0154 COST (3.35)
32.7944
[
19.0802 188.8964
0.8092 0.1908
]
122.67 345.5113 CRIT (3.36)
11.9930
[
30.7018 500.0
0.50 0.50
]
157.97 818.0154 COST (3.38)
Tab. 3.2: Designs for CYP2C19/S-Mephenytoin Experiment under linear cost (3.34)
Fixed costs To examine the effect of incorrectly assumed costs, suppose that true cost is
(3.34), whereas φ(̺) = 1Tr is used in optimal design. Then, COST Problem subject to
Ψ
(
M(̺)
)
≤ 818 is solved by
̺† =

30.7 500
6.0 6.0

 , (3.38)
obtained from (3.18), with φ(̺†) = £158 being higher than even φ(rich) = £123. CRIT
Problem is solved subject to 1Tr ≤ 123 with
̺† =

30.7 500
4.7 4.7

 , (3.39)
such that Ψ
(
M(̺†)
)
= 1356.6 > Ψ
(
M(rich)
)
: the ‘optimal’ design provides less inform-
ation than rich does; see Figure 3.5. Unless realistic costs are considered, design assess-
ment, such as that in Figure 3.1, can be misleading. Indeed, ̺D in Example 3.1 is more
informative than rich per observation but less informative per £ of its φ(̺D) = £263.28.
Nonlinear costs Let the true cost be
φ(̺) = 1.471Tr + 0.0441xTr +
(
1Tr
)2
, (3.40)
nonlinear in r. In one instance of COST Problem, this φ(̺) is minimised subject to
Ψ
(
M(̺)
)
≤ 818, 015.4 by
1.646

23.6295 250.4703
0.2686 0.7314

 , (3.41)
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Fig. 3.5: Every design costs £122.67 according to (3.34). The ellipses (3.12) for ̺∗ in (3.36): ( );
rich: ( ); and ̺† in (3.39): ( ).
which attains Ψ
(
M(̺∗)
)
≈ 818, 015.4, and φ(̺∗) = 8.56 + 1.6462 ≈ 11.266. Another
instance of COST Problem, subject to Ψ(M(̺)) ≤ 81, 801.54, is solved with
4.531

26.4248 320.7078
0.3216 0.6784

 , (3.42)
with Ψ
(
M(̺∗)
)
≈ 81, 801.54, and φ(̺∗) = 30.85 + 4.5312 ≈ 51.384. (Solutions (3.41)
and (3.42) are graphically verified in Example 4.2.)
The two solutions differ in their support points, replications and weights: hence, there
is no equivalence over ω∗. 
3.5.4 Specification of problems
The following discussion is relevant to the choice between CRIT and COST Problems and
to the specification of individual problems.
Example 3.5 (Linear cost constraint vs. nonlinear cost objective).
Let the quantity B = 1 of a compound be allocated to the experiment, with a small
extra could be supplied if absolutely necessary. The compound is the only resource in this
experiment and has valuable uses outside it.
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CRIT Problem is specified as
minimize
RPD
Ψ
(
M(̺)
) (3.43a)
subject to xTr ≤ B, (3.43b)
where xTr is the quantity required by ̺. Constraint (3.43b) does not distinguish between
xTr = 0 and xTr = B, which would be expended at any solution. Since any slightest
excess above B is banned, the implied cost of the compound is
φ(̺) =


0 if xTr ∈ [0, B]
∞ if xTr > B.
(3.44)
See Figure 3.6 and Boyd and Vandenberghe (2004), p. 218 for a general discussion.
Let COST Problem be specified with a nonlinear φ(̺), for instance
minimize
RPD
(
xTr
)10 (3.45a)
subject to Ψ
(
M(̺)
)
≤ c, (3.45b)
where c ∈ rngΨ. The cost φ(̺) =
(
xTr
)10 is incurred if any quantity is used. For any
quantity above B, the cost becomes increasingly prohibitive (and likelier to cause overflow
in numerical implementations) yet the corresponding ̺ is formally allowed. Solutions with
0 < xTr∗ < B are also possible, so that some quantity could be saved. A linear φ(̺) in
(3.45a) may be inadequate as the increase in xTr from 0 to 0.5 is penalised to the same
extent as the increase from 1.0 to 1.5.
A nonlinear objective φ(̺) could also suit such resources as ‘extra samples taken from
a patient’. Solutions ̺∗ do not automatically require an extra sample but allow the experi-
menter to very occasionally take several extra samples. 
The budget in a CRIT Problem can be straightforward to specify, eg, if B is imposed
externally (Elfving, 1952; Fedorov and Hackl, 1997, p. 57; Mead et al., 2012, p. 541). Still,
there is the question of how some B is selected initially. Furthermore, the budget could
limit the maximum expenditure, while the experimenter is free to spend less. A total budget
fixed for the research programme may need to be divided between individual studies and
re-assessed every financial year.
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Fig. 3.6: Cost constraint xTr ≤ 1, in ( ) vs. cost objective φ(̺) = (xTr)10 in ( ).
Targets specification in COST Problems could also be straightforward, especially if
p = 1. Indeed, since some Ψ
(
M(̺)
)
is chosen its values are probably meaningful to the
experimenter. It is also sometimes possible to draw on regulatory guidelines. As regulators
require the information they could stipulate the acceptable level of uncertainty; they are
also aware of the high experimental cost. Since they obviously do not fix the experimental
budget, regulator-driven experimentation may favour the COST approach. However, to
translate regulatory guidelines into criterion targets may be difficult, particularly if p ≥ 2.
The experimenter may also decide to collect more information than the minimum required
by the regulator. Sampling variation also complicates the matter: stricter targets may be
needed to ensure robustness in real experiments.
The costs and benefits of an experiment (or budgets and targets) could also be explored
together: “Everybody will be pleased if the same results can be achieved for less money ...
On the other hand, it may be impossible to draw clear conclusions from an experiment that
is too small, so then the entire cost is wasted” (Bailey, 2008, p. 6). Some strategies for this
exploration are:
• Assess costs and inferences from previous experiments: Should fewer or more obser-
vations have been taken?
• Establish a particular design as a benchmark.
• Evaluate the costs of (hypothetical) decisions made under different levels of uncer-
tainty.
• Construct a Pareto frontier with designs optimised under different targets and budgets;
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and simulate experiments at these designs (Tack and Vandebroek, 2004; Murphy,
Gilmour, and Grabbe, 2003).
• Use previously solved CRIT and COST problems as a guidance.
3.5.5 General formulations
In the following, any criterion function and cost function can be compound.
CRIT Problem. Some Ψ
(
M(̺)
)
is selected and q cost constraints φk(̺) ≤ Bk specified
along with resource budgets Bk > 0 for k = 1, . . . , q.
Problem 3.3 (CRIT).
minimize
RPD
Ψ
(
M(̺)
) (3.46a)
subject to φk(̺) ≤ Bk, k = 1, . . . , q, (3.46b)
where Bk > 0, for k = 1, . . . , q and q ∈ Z++.
A solution to this problem exists, with φk(̺∗) = Bk at least for one k. This problem was
considered over ω in Cook and Fedorov (1995) and (Fedorov and Hackl, 1997, Chapter 4.1).
COST Problem. The experimenter selects a total cost function φ(̺) and specifies m
criterion constraints Ψi
(
M(̺)
)
≤ ci with targets ci ∈ rngΨi for i = 1, . . . ,m.
Problem 3.4 (COST).
minimize
RPD
φ(̺) (3.47a)
subject to Ψi
(
M(̺)
)
≤ ci, i = 1, . . . ,m, (3.47b)
where ci ∈ rngΨi and m ∈ Z++.
A solution exists, with Ψi
(
M(̺∗)
)
= ci at least for one i. Given φ(̺) is linear, this problem
is related to the problem stated in equation (43) of Cook and Fedorov (1995); see Chapter ??
for details.
LOSS Problem. A total cost φ(̺) is selected along with Ψ
(
M(̺)
)
, and some µ > 0 is
chosen to scale the two functions.
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Problem 3.5 (LOSS).
minimize
RPD
Ψ
(
M(̺)
)
+ µφ(̺), (3.48)
where µ > 0.
Practical elicitation of µ can be difficult (Clyde et al., 1995), especially if neither φ(̺∗)
nor Ψ
(
M(̺∗)
)
is known beforehand, unlike with basic CRIT and COST problems. Thus,
several LOSS instances could be solved for different values of µ . Among the problems in
the thesis, LOSS is the closest to the utility-based paradigm of decision-making. Although
LOSS Problem is unconstrained, it is closely connected to COST and CRIT problems via the
Lagrangian framework, with some LOSS and CRIT problems being essentially identical, as
discussed in Chapter 4.
Fedorov (1972), pp. 56–63, used a LOSS-type problem as a starting point in his de-
velopment of optimal designs over ω. LOSS problems under parameter uncertainty are
common in Bayesian optimal design, especially with exact designs (Clyde, 2001; Clyde
et al., 1995; Muller and Parmigiani, 1995). Design applications within Bayesian statistical
decision theory were considered eg, in Raiffa and Schlaifer (1961); and Lindley (1968).
MIXED Problem. The experimenter can specify q ∈ Z+ cost constraints φk(̺) ≤ Bk and
m ∈ Z+ criterion constraints Ψi
(
M(̺)
)
≤ ci, with q +m ∈ Z++. The objective function
is selected from
f0(̺) ∈
{
φ(̺), Ψ
(
M(̺)
)
, Ψ
(
M(̺)
)
+ µφ(̺), ̟(̺)
}
, (3.49)
where ̟(̺) is a penalty function introduced in Chapter 5.
Problem 3.6 (MIXED).
minimize
RPD
f0(̺) (3.50a)
subject to φk(̺) ≤ Bk, k = 1, . . . , q (3.50b)
Ψi
(
M(̺)
)
≤ ci, i = 1, . . . ,m (3.50c)
where each ci ∈ rngΨi and Bk > 0; also q ∈ Z+, m ∈ Z+ and q +m ∈ Z++.
The main application of this problem is to compromise designs in Chapter 5. This problem
generalises the other problems of relaxed design. For instance, if q = 0 in (3.50b) and
f0(̺) = φ(̺), then COST Problem 3.4 results. If both q = 0 and m = 0 are allowed,
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and f0(̺) = Ψ
(
M(̺)
)
+ µφ(̺), then LOSS Problem does. MIXED Problem provides
extra flexibility: eg, a criterion constraint can be introduced into CRIT Problem 3.3. Such
formulations, however, could be less intuitive than pure COST and CRIT problems.
3.6 Standard continuous designs
3.6.1 Single constraint
The standard approach to continuous optimal design is to solve design problems over meas-
ures ω, which satisfy Definition 3.3. This approach is closely related to CRIT Problems
(Elfving, 1952; Fedorov and Hackl, 1997). If φ(̺) = 1Tr and B = 1, CRIT Problem 3.1
takes the following form:
Problem 3.7 (CRIT).
minimize
RPD
Ψ
(
M(̺)
) (3.51a)
subject to
n∑
j=1
rj ≤ 1. (3.51b)
Since φ(̺∗) = B = 1 at any solution, cost constraint (3.51b) is essentially ∑nj=1 rj = 1,
where rj ≥ 0 for all j. Consequently, any solution ̺∗ is also a design measure.
The standard problem of optimal design (Fedorov and Hackl, 1997, p. 28) is stated as
Problem 3.8 (Design measures).
minimize
ω∈W
Ψ
(
M(ω)
)
, (3.52)
where Ψ
(
M(ω)
)
is minimised over ω under the implicit assumption of fixed cost φ(ω) =
∑n
j=1wj = 1. Hence, Problem 3.8 is a special case of Problem 4.2 under φ(̺) = 1Tr.
If φ(̺) = γTr with γ ∈ Rn++ then the normalisation, proposed in Elfving (1952), by this
φ(̺) allows us to apply the standard Problem 3.8. If φ(̺) is nonlinear in replications, the
standard approach does not generally apply.
As illustrated earlier in this chapter, realistic cost functions in enzyme kinetics studies
with ηHM are some φ(̺) = γTr rather than φ(̺) = 1Tr. Yet, all the references found on
optimal design with this model implicitly assumed the latter. (Donev et al., 2008 considered
linear costs in similar experiments, but with a different nonlinear η(x,θ).) This was the case
even when optimal designs for ηHM were justified on the grounds of cost efficiency. For
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instance, Dette et al. (2008), who presented several optimal designs for ηHM , emphasised
the wastefulness of traditional designs and noted that “This critical issue needs to be ad-
dressed because of rising cost in experimentation and the need to rein in cost and time.” Yet
all optimal designs in that paper were based on the implicit assumption of fixed costs per
observation. Likewise, optimal and traditional designs were compared in the paper under
this assumption.
This situation could be partly due to the fact that the standard formulation
minΨ
(
M(ω)
)
, (3.53)
does not contain an explicit cost function. Thus, this design problem can be solved without
considering experimental costs. Of course, since φ(̺) = 1Tr is implicit in the definition
of ω any solution is only optimal if the experimental cost is indeed fixed per observation. A
problem statement, such as
minΨ
(
M(̺)
)
s. t. φ(̺) ≤ B, (3.54)
where φ(̺) is explicit, might be preferable to (3.53). Not only does (3.54) allow for more
general cost functions, but it also draws experimenters’ attention to the very issue of costs.
3.6.2 Several constraints
Constrained designs over ω were considered, eg, in Cook and Fedorov (1995); Fedorov
and Hackl (1997) Chapter 4; Lee (1987, 1988); Cook and Wong (1994); and Clyde and
Chaloner (1996). The equivalent of CRIT Problem 3.3 in this approach is the following
(Fedorov and Hackl, 1997, Chapter 4.1):
Problem 3.9 (Cost constraints).
minimize
ω∈W
Ψ
(
M(ω)
) (3.55a)
subject to φk(ω) ≤ Bk, k = 1, . . . , q, (3.55b)
where Bk > 0, for k = 1, . . . , q and q ≥ 2.
There are some potential difficulties with applying this formulation in experimental
practice.
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• Since every cost functions in (3.55b) must be linear (Fedorov and Hackl, 1997; Cook
and Fedorov, 1995), nonlinear functions φ(̺) are excluded.
• Suppose 200 mg of substrate and 140 mg of inhibitor are available for an enzyme
inhibition study, and there is a constraint on total cost £150. To define Problem
3.9, the experimenter must normalise all these amounts per one observation, and then
recover these amounts from a design solution ω∗. (In CRIT Problem 3.3, all these
quantities can be specified directly.) This required normalisation also assumes that
every experiment has a constraint on N , which need not always be the case.
• Problem 3.9 need not be feasible under normal circumstances, and a solution ω∗ may
simply not exist. (Feasibility in CRIT Problems is guaranteed, unless incompatible
constraints are deliberately specified.)
• The constraint
∑n
j=1 rj = 1 in Problem 3.9 may lead to suboptimal solutions, eg, if
N∗ = 0.5 replications is in fact optimal.
The standard problem with criterion constraints is the following (Fedorov and Hackl,
1997 Chapter 4.2 and Cook and Fedorov, 1995):
Problem 3.10 (Criterion constraints).
minimize
ω∈W
Ψ0
(
M(ω)
) (3.56a)
subject to Ψ
(
M(ω)
)
≤ ci i = 1, . . . ,m. (3.56b)
In this framework, the experimenter selects the most important criterion, with the func-
tion Ψ0
(
M(ω)
)
, and also m auxiliary criteria, with functions Ψ
(
M(ω)
)
for i = 1, . . . ,m.
Problem feasibility and solution existence are not guaranteed. Indeed, with relaxed designs,
we can choose any design, say rich with N = 120, as the benchmark, and simply set cri-
terion targets as ci = Ψi
(
M(rich)
)
. A design measure may simply not exist that provides
as much information as this rich. Furthermore, the specified targets for the auxiliary cri-
teria might be so stringent that little information would be possible to obtain, using ω∗, for
the main criterion. As with standard Problem 3.8, there is the implicit assumption of fixed
cost per observation.
An alternative is to specify the following MIXED Problem:
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Problem 3.11 (MIXED).
minimize
RPD
φ(̺) + µΨ0
(
M(̺)
) (3.57a)
subject to Ψi
(
M(̺)
)
≤ ci, i = 1, . . . ,m (3.57b)
where µ > 0, and each ci ∈ rngΨi.
(Note that existence of solutions to this problem is only conjectured but not proven in this
thesis.) This formulation, however, requires an appropriate constant µ > 0 be defined to
scale φ(̺) and Ψ0
(
M(̺)
)
. There is also a risk to specify overly stringent targets in (3.57b)
for the auxiliary criteria. A more straightforward approach could be to use COST Problem
3.4 with the constraint Ψ0
(
M(̺)
)
≤ c0 defined for the most important criterion, where c0
is appropriately stringent.
Another approach to constrained continuous design was implemented in Clyde and
Chaloner (2002), who solved design problems over continuous designs with a fixed total
N > 0 observations. Thus, the constraint
∑n
j=1 rj = N , rather than
∑n
j=1 rj = 1 was
imposed. This approach resolved some difficulties, eg, with problem feasibility. Still, since
any solution had to have N observations, the solutions could be expensive.
4. RELAXED DESIGNS
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This chapter develops optimisation methodology for relaxed designs. This methodology
builds upon generic methods of convex differentiable optimisation subject to constraints,
which is described in Fletcher (1987), Nocedal and Wright (2006), Bertsekas (2003), Avriel
(1976), Sundaram (1996), Boyd and Vandenberghe (2004) and Lasdon (2002). These meth-
ods and other mathematical background are reviewed in appendix A. The chapter considers
results on existence and verification of optimal relaxed designs; as well as on equivalence
between design problems. This discussion would enable specification of design problems
in standard software and checking the solutions obtained.
4.1 Optimisation variable
We assume that the experimenter defines a design grid, X , containing distinct design points
xj ∈ X , where j = 1, . . . , n. Any convenient X could be specified; the only formal re-
quirement is that Assumption 4.1 be satisfied. This X is fixed in the design problem, and
only the replication of each xj ∈ X is sought.
Definition 4.1. The optimisation variable in a design problem with some fixed X is a vector
r = (r1, r2, . . . , rn)
T (r ∈ Rn), (4.1)
whose element rj is the replication of xj ∈ X , for j = 1, . . . , n.
For mathematical convenience we allow r with negative elements, whereas the physical
requirement r ∈ Rn+ is ensured separately. A design solution is some r∗ = (r∗1, . . . , r∗n)T ,
such that r∗ ∈ Rn+, whose element r∗j ≥ 0 is the replication of xj ∈ X . The notation n∗,
such that n∗ ≤ n, shall denote the number of positive r∗j in r∗, and hence the number of
support points in the optimal design.
Definition 4.2 (Ordering of vectors). Two vectors a and b in Rn are ordered as
(i) a ≥ b if aj ≥ bj for all j;
(ii) a > b if aj ≥ bj , ∀j, with at least one aj > bj;
(iii) a >> b, ie a is strictly greater than b, if aj > bj , ∀j.
This ordering is partial if n ≥ 2.
Definition 4.3 (Monotonicity over a set). Let f : D → U , where D ⊆ Rn, have rng f ⊆ U
endowed with a (partial) order ≤. Let a and b be two arbitrary vectors in S ⊆ D. Then the
function over S is
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Decreasing: f(a) ≤ f(b) if a ≥ b and f(a) < f(b) if a >> b;
Strictly decreasing: f(a) < f(b) if a > b;
(Strictly) increasing: if −f(r), where r ∈ S, is (strictly) decreasing.
4.2 Modelling expected information
4.2.1 Sensitivity matrices
Given the assumed η(x,θ) and θ∗, we evaluate the sensitivity matrix at each fixed xj as
g(xj) =
(
∂ η(xj ,θ)
∂ θ
)(
∂ η(xj ,θ)
∂ θ
)T
(j = 1, . . . , n), (4.2)
and collect these n matrices into the following set:
Definition 4.4. A sensitivities grid is a finite set M = {g1,g2, . . . ,gn} whose jth element
is gj = g(xj) where xj belongs to X for j = 1, . . . , n.
Like X , this M is fixed in the design problem. The information matrix of a solution r∗ ∈
R
n
+ is later defined as
∑n
j=1 r
∗
jgj , where r∗j ≥ 0 is the replication of the fixed gj in M for
j = 1, . . . , n.
As reviewed in Section A.2, the set Sp of symmetric p× p matrices is isomorphic to Rp˜,
where p˜ = p(p+ 1)/2. Each gj belongs to S
p
+ ⊂ S
p and maps one-to-one to some vector
v ∈ Rp˜.
Example 4.1. DATA : ηHM ; (V ∗,K∗) = (10, 35); σ2 = 1; X = [0, 500].
We fix X = {0, 10, 20, . . . , 490, 500} with n = 51 equally spaced points and compute
M. Since p = 2 and p˜ = 3, the elements of M map to R3; see Figure 4.1. For instance,
the points {10, 30, 90} in X map to the linearly independent vectors
g(10)→


0.049
−0.011
0.002

 ,g(30)→


0.213
−0.033
0.005

 ,g(90)→


0.518
−0.042
0.003

 . (4.3)
Any matrix in S2+ is a linear combination of some matrices in this M, eg, of those in (4.3).
If M contained fewer than three linearly independent matrices, only a subset of S2+ could
be expressed with the elements of M. 
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Fig. 4.1: The partial boundary of S2+ is shown in grey. Each circle corresponds to one of 51 matrices
in M in Example 4.1. The coloured circles indicate {g(10)•, g(30)•, g(90)•} from (4.3),
that comprise a basis for S2.
In the following, we require proper X and M that satisfy
Assumption 4.1. Let θ have p elements and p˜ = p(p+ 1)/2. Then, X contains n ≥ p˜
points xj , where j = 1, . . . , n, such that p˜ matrices inM are linearly independent and thus
form a basis for Sp.
If this assumption is satisfied X could have as few as n = p˜ points. In practice, a finer X
with n >> p˜ would often produce better solutions. The proposed methods of design optim-
isation do not apply if n ∈ [p, p + 1, . . . , p˜), although their extension could be straightfor-
ward. The proposed verification of design optimality applies to any nondegenerate design.
4.2.2 Linear combinations
A linear combination of the n elements of M is
H(r) =
n∑
j=1
rjgj (gj ∈ M, r ∈ R
n), (4.4)
which is also a linear function H : Rn → Sp. The range of H(r) equals Sp and conveniently
includes Sp+ and S
p
++. Since we ultimately require nonnegative replications, the following
is relevant.
Proposition 4.1. Any H(r), such that r ∈ Rn+, equals some H(a) =
∑p˜
j=1αjgj , where
a ∈ Rp˜+ is unique and gj , for j = 1, . . . , p˜, are linearly independent.
4. Relaxed designs 57
This proposition rephrases the Caratheodory’s theorem stated in Bertsekas et al. (2003)
Chapter 1.3; see also Theorem 1 on p. 62 of Magaril-Il’yaev and Tikhomirov (2003).)
Lemma 4.1. If a and b in Rn satisfy b > a then H(b) ≥ H(a).
Proof If b > a, then c = b − a > 0, and therefore c ∈ Rn+. The matrix H(b) −H(a) =
H(c) =
∑n
j=1cjgj is positive semidefinite. 
Proposition 4.2. H(r) is positive definite for any r ∈ Rn++.
Proof Suppose first that M only contains n = p˜ basis matrices for Sp. An arbitrary A ∈
S
p
++ can be expressed in the elements of M as
A =
n∑
j=1
ajgj , (4.5)
where a ∈ Rn is uniquely determined. Choose an arbitrary r ∈ Rn++ and suppose that
a 6= r, as otherwise the proposition holds. Define b whose
bj =


rj, if aj ≤ rj
aj, otherwise,
(4.6)
where j = 1, . . . , n, and thus b ∈ Rn++. The corresponding H(b) = A +
∑n
j=1(bj −
aj)gj ≥ A is positive definite, which proves the case if b = r. Finally, if r has some
rj < aj then define
κ = min{
r1
b1
, . . . ,
rn
bn
}, (4.7)
where κ ∈ (0, 1), since bj ≥ rj for all j, with at least one bj > rj , and since all rj and
bj positive. Consider the vector c = 0.5κb, which satisfies c ∈ Rn++ and c < r. The
corresponding matrix H(c) = 0.5κH(b) is in Sp++ as a positive multiple of a H(b) ∈ S
p
++.
Lemma 4.1 implies that given r > c, the matrix H(r) ≥ H(c) and thus H(r) ∈ Sp++.
Suppose now that n > p˜ and place the basis matrices gj ∈ M in the first p˜ slots in M.
For an arbitrary r ∈ Rn++, define v ∈ Rn+ such that v = (r1, . . . , rp˜, 0, 0, . . . , 0) with the
first p˜ elements equal those in r. The above proof holds for v, and thus H(v) ∈ Sp++. Since
r > v, the matrix H(r) ≥ H(v), by Lemma 4.1, and therefore H(r) ∈ Sp++. 
Proposition 4.3. H(r) is positive definite for some r ∈ Rn+ that have up to n − p zero
elements.
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Proof For any a ∈ Rn++, the matrix H(a) is in S
p
++. By Proposition 3.1, some p matrices
inMmust be obtained from linearly-independent vectors ∂ η(xj ,θ)/∂ θ. That proposition
states that the p such matrices in M are sufficient for H(a) ∈ Sp++. Thus, all the rj that do
not correspond to p linearly independent matrices can be set to zero.
4.2.3 Information matrix
Definition 4.5. The informative domain P ⊂ Rn is the pre-image of Sp++ under H : Rn →
S
p defined in (4.4) over a proper M with n elements.
In other words, the matrix H(r) is positive definite iff r ∈ P.
Proposition 4.4. The set P
(i) satisfies Rn++ ⊆ P;
(ii) is convex and open;
(iii) is such that if a ∈ P then any b > a belongs to P.
Proof (i) That Rn++ ⊆ P is by definition of P and Proposition 4.2. (ii) Since Sp++ is convex,
so is its pre-image P under a linear mapping. The second property follows, as P is the pre-
image of Sp++, an open subset of Sp, whereas H(r) is a continuous function from Rn to
S
p
, which are topological spaces (eg, Kolmogorov and Fomin (1975), p. 87). (iii) Holds by
Lemma 4.1. 
Since, eg, 0 /∈ P, the set P does not contain Rn+, although by Proposition 4.3, P contains
some r ∈ Rn+ that have up to n− p zero coordinates. We note that P = Rn++ only occurs if
both p = 1 and a proper M contains just one non-zero element.
Occasionally, we require P ⊂ Rn, which is the pre-image of Sp+ under H, that is, P is
the set of all r ∈ Rn such that H(r) ∈ Sp+. By an argument similar to the above proof,
P 6= ∅ is convex and closed. Also, P is an open proper subset of P, and thus P is the closure
of P. A vector v ∈ P is called degenerate if v /∈ P and nondegenerate otherwise.
To simplify the notation let the observation errors in Assumption 2.1 satisfy e ∼ N (0, IN ),
and therefore σ2 ≡ 1. To emphasise the assumption σ2 = 1 we denote the information mat-
rix of ̺ as G(̺).
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Definition 4.6. Suppose that Assumption 2.1 holds with σ2 = 1, and a proper M is given.
The information matrix is a function G : P→ Sp++ such that
G(r) =
n∑
j=1
rjgj (gj ∈M, r ∈ P), (4.8)
where P ⊂ Rn.
Consequently, G(r) is defined only for vectors r ∈ P, possibly with some elements rj < 0.
The range of G(r) equals Sp++, ie, coincides with the co-domain. The function is linear
and convex, since its domain is convex.
Proposition 4.5. The function G(r) is increasing over its domain P.
Proof Let arbitrary vectors a and b in P be comparable by Definition 4.2. If a > b, then
G(a) ≥ G(b) by Lemma 4.1. To show that a >> b implies G(a) > G(b) we note that
a >> b implies a − b = c ∈ Rn++ and G(c) = G(a) − G(b) is positive definite by
Proposition 4.2.
The function G(r) is differentiable everywhere in its domain. Since P is open, the
partial derivative is
∇rjG(r) = ∇rj(r1g1 + . . .+ rngn) = gj (r ∈ P), (4.9)
which is similar to the standard functional derivative (A.4), whereas the gradient of G(r) is
identical to (A.5).
4.3 Criterion functions
Definition 4.7. Let a proper M be fixed. The criterion function ψ : P→ R is a composite
mapping ψ = Ψ ◦ G, where G : P → Sp++ is the information matrix (4.8) defined over
M. The function Ψ : Sp++ → R satisfies Definition 3.7 and is such that ψ(r) satisfies the
following properties (unless stated otherwise, any vector belongs to P):
(i) ψ(a) < ψ(b), implies that a is more informative than b;
(ii) ψ(r) is decreasing over P: If a > b, then ψ(a) ≤ ψ(b) in every case, with ψ(a) <
ψ(b) if G(a) > G(b). If a >> b then ψ(a) < ψ(b) strictly.
(iii) rngψ = (α,∞) where α ∈ [−∞,∞).
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(iv) For any convergent sequence {r(ι)} ∈ P such that limι→∞ r(ι) = v where v ∈ P is
degenerate, ψ(r(ι))→∞ as ι→∞.
(v) ψ(r) is convex and differentiable over P.
Note that property (iii) implies rngψ is an open interval in R, which clearly holds since
P and Sp++ are open sets. Also, ψ(r) = ∞ and ψ(r) = −∞ are excluded since any
nondegenerate design, whose G(r) ∈ Sp++ provides at least some information on θ, but
not an infinite amount. Property (iv) implies, eg, that if r → 0 the information in G(r)
becomes infinitesimally small.
A-criterion function
Function (3.9) is defined over P as
ψ(r) = trG−1(r) =
p∑
l=1
E−1l (r), (4.10)
where El > 0 is eigenvalue l of G(r), with rngψ = (0,∞). Property (ii) is by mono-
tonicity of Ψ(G) = trG−1 over Sp. Since Ψ is convex over Sp++ so ψ(r) is convex over
P. To justify property (iv) we note that if r(ι) approaches a degenerate v ∈ P as ι→∞,
then G(r(ι))→ H(v) elementwise. (That G(r(ι))→ H(v) is by continuity of H(r) over
R
n
.) The eigenvalues of G(r(ι)) approach those of H(v), since the coefficients of the char-
acteristic polynomial of a matrix are polynomial functions of the matrix entries (Horn and
Johnson, 1985, p. 540). Since a square matrix is degenerate iff at least one eigenvalue is
zero property (iv) follows from (4.10).
The partial derivative of (4.10) with respect to rj is
∇jψ(r) = tr∇jG
−1(r) = −tr
{
G−2(r)gj
}
, (4.11)
from (4.9) and since ∇jtrG(r) = tr∇jG(r); Harville (1997), p. 300.
D-criterion function
The D-criterion function is defined as
ψ(r) = − ln |G(r)| = − ln |
n∑
j=1
rjgj| (r ∈ P, gj ∈ M), (4.12)
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which is convex, by convexity of Ψ(G) = − ln |G| over Sp++, and has rngψ = (−∞,∞).
Property (iv) is shown by noting that |G(r)| =∏pl=1El(r) and using a similar argument as
for the A-criterion function. Property (ii) is strengthened as follows.
Proposition 4.6. For any a and b in P such that a > b function (4.12) satisfies ψ(a) <
ψ(b).
Proof Without loss of generality, let aj > bj and the remaining n − 1 elements of a be
equal to the corresponding elements of b. Then
|G(a)| = |G(b) + (aj − bj)gj| > |G(b)|, (4.13)
by Harville (1997), Theorem 18.1.6, since G(b) ∈ Sp++; aj − bj > 0 and gj 6= 0 ∈ Sp+.
Consequently, − log |G(a)| < − log |G(b)| for any a > b in P. 
The partial derivative of (4.12) with respect to rj is (Boyd and Vandenberghe, 2004,
p. 643)
∇jψ(r) = −tr
{
G−1(r)gj
}
(r ∈ P), (4.14)
where G−1(r) exists, since G(r) ∈ Sp++.
The following result is analogous to Lemma 2.2.1 proven in Fedorov (1972) for design
measures.
Proposition 4.7. If G(r) ∈ Sp++ then
−
n∑
j=1
rj {∇jψ(r)} = p (r ∈ P), (4.15)
where p is the number of parameters in θ.
Proof Following Fedorov (1972) we write
−
n∑
j=1
rj {∇jψ(r)} =
n∑
j=1
rjtr
{
G−1(r)gj
}
=
n∑
j=1
tr
{
G−1(r)rjgj
} (4.16)
= tr


n∑
j=1
G−1(r)rjgj


= tr

G−1(r)
n∑
j=1
rjgj


= tr
{
G−1(r)G(r)
}
= tr Ip = p.
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This derivation used the standard results on matrix traces; eg Harville (1997). 
4.4 Cost functions
The experimental cost is formulated as a function φ(r) of r ∈ Rn. The notation φ(rj+)
denotes the restriction of a given φ(r) to vectors r ∈ Rn+ such that
r = (0, . . . , 0, rj+, 0, 0)
T , rj+ ∈ [0,∞), (4.17)
where all, except jth, elements are fixed at zero.
Definition 4.8. The cost function φ : Rn → R computes the cost of a vector r ∈ Rn defined
over a fixed X . This φ(r) has the following properties:
(i) φ(r) is convex and differentiable over Rn.
(ii) φ(r) achieves its global minimum over Rn+ iff r = 0, in which case φ(0) = 0.
(iii) For each j = 1, . . . , n the function φ(rj+) has rng = [0,∞), with φ(rj+) = 0 iff
rj+ = 0
⇒ rng φ = [0,∞) for φ(r) restricted to Rn+;
(iv) φ(r) strictly increases over Rn+
⇔ each φ(rj+), where j = 1, . . . , n, is strictly increasing over rj+ ∈ [0,∞)
The monotonicity in (iv) is weakened in Section 4.5.1 for problems with several cost con-
straints. If each individual φk(r) satisfies this definition, so does
φ(r) =
q∑
k=1
vkφk(r) (vk > 0). (4.18)
Definition 4.8 is satisfied given any φ(̺) in Section 3.4, except for (3.28). A particular
φ(̺) is re-stated as φ(r) in the obvious way: eg,
φ(r) = γTr + v(1T r)2 (v > 0,γ ∈ Rn+, r ∈ R
n), (4.19)
for(3.29).
4. Relaxed designs 63
4.5 Results on design problems
The results in this section were developed using methods of convex differentiable optimisa-
tion with constraints, which is reviewed in Appendix B.
We assume that the design problem is specified with a proper M, at least one ψ : P →
R and at least one φ : Rn → R that satisfy Definitions 4.7 and 4.8, respectively. The
optimisation domain is
domψ(r) ∩ domφ(r) = P ∩ Rn = P (4.20)
where every ψ(r) and φ(r) are defined. Every problem includes the constraint r ∈ P+,
where
P+ = P ∩ R
n
+, (4.21)
is convex and nonempty. Any r ∈ P+ is physically possible and nondegenerate.
Proposition 4.8. If a ∈ P+ then any b > a also belongs to P+.
Proof Since a ∈ Rn+ the vector b ∈ Rn+. By Lemma 4.1, the matrix H(b) ≥ H(a) and
therefore H(b) ∈ Sp++. 
4.5.1 CRIT Problem
CRIT Problem is defined with some ψ(r) in the objective and with q cost constraints
φk(r) ≤ Bk. For mathematical convenience, we also impose the dummy constraint ψ(r) ≤
cd.
Problem 4.1 (DUMMY CRIT).
minimize
R
n
ψ(r) (4.22a)
subject to r ∈ P+, (4.22b)
φk(r) ≤ Bk (k = 1, . . . , q), (4.22c)
ψ(r) ≤ cd, (4.22d)
where Bk > 0 and cd = ψ(0.5b) for any b ∈ Rn++ such that φk(b) < Bk for k = 1, . . . , q
and q ∈ Z++.
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The same ψ(r) is defined in (4.22a) and in (4.22d). Some b exists by Proposition 4.9.
The budget -constrained set for cost constraint k is
Γk = {r ∈ R
n |φk(r) ≤ Bk} (Bk > 0), (4.23)
which is nonempty, since Bk ∈ rng φq, and convex. The budget-constrained set for the
problem is
Γ =
q⋂
k=1
Γk, (4.24)
which is convex. The criterion-constrained set is
Υ = {r ∈ P |ψ(r) ≤ cd} (cd ∈ rngψ), (4.25)
which is convex and nonempty, since cd ∈ rngψ. The feasible set for Problem 4.1 is
Ω = P+ ∩ Γ ∩Υ = R
n
+ ∩ Γ ∩Υ, (4.26)
which is convex and, as shown below, nonempty. If a vector r ∈ Rn belongs to Ω, this r
is feasible and infeasible otherwise. Since these sets are convex, and the problem functions
are convex, Problem 4.1 is convex, as is every subsequent design problem.
Existence of a solution
Proposition 4.9. Problem 4.1 is strictly feasible: there exists b ∈ Rn++ such that ψ(b) < cd
and φk(b) < Bk for all k.
Proof By Definition 4.8, there is a unique a(k)j > 0 such that φk(rj+) = Bk iff rj+ = a
(k)
j .
Let aj = min(a
(1)
j , . . . , a
(q)
j ), and ǫj = (0, . . . , 0, 1, 0, . . . , 0)T be a n× 1 vector whose
jth element is one. Consider vectors
ajǫj = (0, . . . , 0, aj , 0, 0)
T (aj ∈ (0,∞)), (4.27)
where j = 1, . . . , n. Since every φk(rj+) is strictly increasing, φk(ajǫj) ≤ Bk, ∀k, and
thus ajǫj ∈ Γ,∀j. Define
v = ω1a1ǫ1 + . . . + ωnanǫn = (ω1a1, . . . , ωnan)
T (ωj > 0,
n∑
j=1
ωj = 1), (4.28)
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with v ∈ Rn++, as all aj and ωj are positive. As a convex combination of ajǫj ∈ Γ, the
vector v ∈ Γ, by convexity of Γ, and therefore φk(v) ≤ Bk, ∀k. Define b = κv, where
κ ∈ (0, 1), which belongs to Rn++ and satisfies φk(b) < Bk, ∀k, since b << v and each
φk(r) is strictly increasing over Rn+. Finally, ψ(b) < cd = ψ(0.5b), since ψ(r) is decreas-
ing and b >> 0.5b. 
Given Problem 4.1 with q ≥ 2 cost constraints, Proposition 4.9 and the ensuing results
still hold if each φk(r) is merely increasing over Rn+, provided that for each j ∈ {1, . . . , n}
some φk(rj+) is strictly increasing over rj+ ∈ [0,∞). For example, let the cost constraints
be r3 ≤ B1 and r21 + r22 ≤ B2. Since the value of, say, r3 has no bearing on the latter
constraint, we simply set a3 = a
(1)
3 = B1.
Lemma 4.2. The set Γ ∩ Rn+ in Problem 4.1 is bounded and closed.
Proof The numbers aj ∈ (0,∞) from Proposition 4.9 define bounded intervals [0, aj ],
where j = 1, . . . , n. Thus, A = [0, a1] × . . . × [0, an] is a bounded subset of Rn+. Any
r ∈ Rn+ ∩ Γ must have each rj ∈ [0, aj], and thus r ∈ A. Otherwise, if rj > aj for any j
then r > ajǫj and φk(r) > φk(ajǫj) = Bk for some k. Consequently, Γ ∩Rn+ ⊆ A and is
bounded.
Let an arbitrary convergent sequence {r(ι)} of some r(ι) ∈ Γk converge to v ∈ Rn as
ι→∞. Since φk(r) is continuous everywhere in Rn, this v satisfies
φk(v) = lim
ι→∞
φk(r
(ι)) ≤ Bk,
and hence v ∈ Γk. Thus, Γk contains all its limit points and is closed; hence, Γ ∩ Rn+ =⋂q
k=1 Γk ∩ R
n
+ is closed as the intersection of finitely many closed sets. 
Lemma 4.3. Given any cd ∈ rngψ the set Υ is closed.
Proof Let an arbitrary convergent sequence {r(ι)} of some vectors inΥ satisfy limι→∞ r(ι) =
v. This v ∈ P, since Υ ⊂ P and P is the closure of P; see Section 4.2.3. Unless v ∈ P, there
is a contradiction. Indeed, if v /∈ P then Definition 4.7 implies ψ(r(ι))→∞ as ι→∞, and
therefore for some ι and l ∈ Z++ the inequality ψ(r(ι)) > cd holds for all ι ≥ l, implying
r(ι) /∈ Υ for every ι ≥ l. The continuity of ψ(r) implies ψ(v) = lim
r
(ι)→v ψ(r
(ι)) for
ι→∞, where ψ(r(ι)) ≤ cd for every ι, since r(ι) ∈ Υ. Therefore, ψ(v) ≤ cd and v ∈ Υ.
4. Relaxed designs 66

Some r∗ ∈ Ω is a solution to Problem 4.1 if this r∗ is a global minimiser of the objective
ψ(r) over Ω; see Definition A.7. By convexity, any minimiser of ψ(r) over Ω is global, but
possibly non-unique.
Proposition 4.10. A solution r∗ ∈ Ω to Problem 4.1 exists.
Proof The set Ω = Rn+ ∩ Υ ∩ Γ is closed, as the intersection of closed sets, and bounded,
since Rn+ ∩ Υ is bounded. A closed bounded subset of Rn is compact. Since Ω 6= ∅ by
Proposition 4.9, and since ψ(r) in (4.22a) is continuous, a solution r∗ ∈ Ω exists by the
Weierstrass Theorem A.1.
Characterisation of solutions
Proposition 4.11. The criterion constraint (4.22d) is inactive at any r∗ ∈ Ω; that is,
ψ(r∗) < cd.
Proof Since r∗ ∈ Ω we only check ψ(r∗) = cd. By Proposition 4.9 some b ∈ Ω satisfies
ψ(b) < cd = ψ(r
∗), which contradicts the global optimality of r∗ over Ω. 
The dummy constraint ψ(r) ≤ cd therefore ensures the existence, but does not affect the
value, of r∗. We now restate Problem 4.1 in a simplified form.
Problem 4.2 (CRIT).
minimize
r∈P+
ψ(r) (4.29a)
subject to φk(r) ≤ Bk (k = 1, . . . , q), (4.29b)
where P+ ⊂ Rn, and Bk > 0 for k = 1, . . . , q and q ∈ Z++.
The feasible set is now Ω = P+ ∩ Γ.
Associated with Problem 4.2 is the Lagrangian function L : P× Rq+ → R
L(r,λ) = ψ(r) +
q∑
k=1
λk(φk(r)−Bk) (r ∈ P, λ ∈ R
q
+), (4.30)
where λ contains q Lagrange multipliers, with the multiplier λk ≥ 0 for the constraint k in
(4.29b).
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Optimal Lagrange multipliers λ∗ = (λ∗1, . . . , λ∗q)T characterise a solution r∗ to Prob-
lem 4.2. If λ∗k = 0, the cost constraint k is either inactive at r∗, if φk(r∗) < Bk, or weakly
active, if φk(r∗) = Bk. Whenever λ∗k > 0, the constraint k satisfies φk(r∗) = Bk and is
strongly active. Let qˆ ∈ {1, . . . , q} denote the number of the strongly active cost constraints
at a solution to Problem 4.2; as shown below, qˆ ≥ 1. Without loss of generality, let the cost
constraint k be strongly active if k ∈ {1, . . . , qˆ} and be otherwise if k ∈ {qˆ + 1, . . . , q}.
Correspondingly, the first qˆ elements of λ∗ are denoted as
λˆ
∗
= (λ∗1, . . . , λ
∗
qˆ)
T , (λˆ
∗
∈ Rqˆ++). (4.31)
Proposition 4.12. The following hold for Problem 4.2:
(i) A solution to the problem exists.
(ii) Some r∗ ∈ Ω is a solution if and only if there exists λ∗ ∈ Rq+ such that
∇jL(r
∗,λ∗) = ∇j
(
ψ(r∗) +
q∑
k=1
λ∗kφk(r
∗)
)
≥ 0 (∀j), (4.32)
with ∇jL(r∗,λ∗) = 0 if r∗j > 0.
(iii) φk(r∗) = Bk and λ∗k > 0 for k = 1, . . . , qˆ, where qˆ ∈ {1, . . . , q}.
(iv) λˆ∗ ∈ Rqˆ++ is bounded. If the n× 1 gradient vectors ∇φk(r∗), where k = 1, . . . , qˆ,
are linearly independent, λˆ∗ is unique.
Notably, part (ii) implies ∇jL(r∗,λ∗) = 0 at every r∗j > 0, and the corresponding xj is a
support point of the optimal design.
Proof Part (i) is by equivalence of Problem 4.2 with Problem 4.1. Part (ii) applies conditions
(A.26a) and (A.26b) of Karush-Kuhn-Tucker Theorem A.4. Part (iv) is by Proposition A.3.
The statements in part (iii), except for qˆ ≥ 1, are by complimentarity condition (A.26c) of
Theorem A.4 and by definition of strongly active constraints.
That at least one λ∗k > 0 is shown by contradiction. Since λ
∗ ∈ Rq+ by Theorem A.4,
let λ∗ = 0. Then, condition (4.32) becomes
∇jL(r
∗,λ∗) = ∇jψ(r
∗) ≥ 0, (4.33)
where r∗ ∈ Ω and thus r∗ ∈ P+. Define r† = r∗ + ǫ, where n× 1 vector ǫ contains
small constants ǫ > 0; hence r† ∈ Rn++ and r† >> r∗. Since ψ(r) is decreasing, ψ(r†)−
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ψ(r∗) < 0, with
ψ(r†)− ψ(r∗) ≈
n∑
j=1
∇jψ(r
∗)ǫ, (4.34)
ie, is approximately the total differential of ψ(r) at r∗. Since ǫ > 0, the expression (4.34)
is negative only if ∇jψ(r∗) < 0 at least for some j. 
4.5.2 COST Problem
COST Problem has a cost function φ(r) as its objective and incorporates m criterion con-
straints ψi(r) ≤ ci. For mathematical convenience, we impose a dummy cost constraint on
this φ(r).
Problem 4.3 (DUMMY COST).
minimize
R
n
φ(r) (4.35a)
subject to r ∈ P+, (4.35b)
ψi(r) ≤ ci (i = 1, . . . ,m), (4.35c)
φ(r) ≤ Bd, (4.35d)
where m ∈ Z++, each criterion target is ci ∈ rngψi, and Bd = φ(2b) where b ∈ Rn++
satisfies ψi(b) < ci for i = 1, . . . ,m.
A vector b exists by Proposition 4.13. The budget-constrained set is
Γ = {r ∈ Rn |φ(r) ≤ Bd}, (4.36)
where Bd > 0 since 0.5b ∈ Rn++. Let
Υi = {r ∈ P |ψi(r) ≤ ci} (ci ∈ rngψi), (4.37)
so that the criterion-constrained set is
Υ =
m⋂
i=1
Υi (Υ ⊂ P), (4.38)
and the feasible set is
Ω = P+ ∩ Γ ∩Υ = R
n
+ ∩ Γ ∩Υ. (4.39)
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Proposition 4.13. Problem 4.3 is strictly feasible: there is some b ∈ Rn++ such that ψi(b) <
ci for i = 1, . . . ,m and φ(b) < Bd.
Proof Let i = 1 and note that since c1 ∈ rngψ1 there is some a1 ∈ P such that
ψ1(a1) = c1. Define b1 = a1 + v, where v ∈ Rn++ is such that b1 ∈ Rn++. Since
b1 >> a1 and ψ1 is decreasing, ψ1(b1) < c1. We similarly obtain vectors bi ∈ Rn++
such that ψi(bi) < ci, where i = 2, . . . ,m. Let b =
∑m
i=1bm, which is b >> bi and thus
ψi(b) < ci for all i. Also, φ(b) < Bd according to the problem statement. 
Proposition 4.14. A solution r∗ ∈ Ω to Problem 4.3 exists. Constraint (4.35d) is inactive
at any r∗.
By Lemma 4.3, each Υi is closed, and thus Υ =
⋂m
i=1Υi is closed. The rest of the proof is
identical to those of Propositions 4.10 and 4.11.
The simplified formulation is
Problem 4.4 (COST).
minimize
r∈P+
φ(r) (4.40a)
subject to ψi(r) ≤ ci (i = 1, . . . ,m), (4.40b)
where P+ ⊂ Rn and ci ∈ rngψi for i = 1, . . . ,m.
The feasible set is now Ω = P+ ∩Υ = Rn+ ∩Υ. The Lagrangian L : P× Rm+ → R is
L(r,λ) = φ(r) +
m∑
i=1
λi(ψi(r)− ci) (r ∈ P, λ ∈ R
m
+ ), (4.41)
where λ contains m Lagrange multipliers, with the multiplier λi ≥ 0 for the constraint i in
(4.40b). The optimal multipliers at some r∗ are λ∗ = (λ∗1, . . . , λ∗m)T . Let mˆ ∈ {1, . . . ,m}
be the number of the strongly active criterion constraints at r∗; as shown below, mˆ ≥ 1.
Let the constraint i be strongly active at r∗ if i ∈ {1, . . . , mˆ} and be otherwise if i ∈
{mˆ+ 1, . . . ,m}. The first mˆ elements of λ∗ are
λˆ
∗
= (λ∗1, . . . , λ
∗
mˆ)
T , (λˆ
∗
∈ Rmˆ++). (4.42)
Proposition 4.15. The following hold for Problem 4.4:
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(i) A solution to the problem exists.
(ii) Some r∗ ∈ Ω is a solution if and only if there exists λ∗ ∈ Rm+ such that
∇jL(r
∗,λ∗) = ∇j
(
φ(r∗) +
m∑
i=1
λ∗iψi(r
∗)
)
≥ 0 (∀j), (4.43)
with ∇jL(r∗,λ∗) = 0 if r∗j > 0.
(iii) ψi(r∗) = ci and λ∗i > 0 for i = 1, . . . , mˆ, where mˆ ∈ {1, . . . ,m}.
(iv) λˆ∗ ∈ Rmˆ++ is bounded. If the n× 1 gradients ∇ψi(r∗), where i = 1, . . . , mˆ, are
linearly independent, λˆ∗ is unique.
Proof The proof is identical to that of Proposition 4.12, except for the existence of λ∗i > 0.
Since λ∗ ∈ Rm+ by Karush-Kuhn-Tucker Theorem A.4, let λ∗ = 0. Then, (ii) implies
∇jL(r
∗,λ∗) = ∇jφ(r
∗) = 0 (r∗ ∈ Ω) (4.44)
for every r∗j > 0. However, φ(r) is strictly increasing over Rn+ and thus ∇jφ(r∗) > 0 if
r∗j > 0. 
4.5.3 Problem equivalence
We now consider some results on equivalence between CRIT and COST problems. Related
results in standard optimal design over ω were considered in Cook and Wong (1994); and
Clyde and Chaloner (1996).
Compound ψ(r) in CRIT Problem
Let CRIT Problem be specified as
minimize
r∈P+
ψ(r) =
m∑
i=1
hiψi(r) (4.45a)
subject to φ(r) ≤ B, (4.45b)
where B > 0 and hi > 0 for i = 1, . . . ,m are the coefficients in the compound criterion
function ψ(r). Let r∗ solve this problem and denote ψ∗i = ψi(r∗) for i = 1, . . . ,m. Let
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COST Problem be specified as
minimize
r∈P+
φ(r) (4.46a)
subject to ψi(r) ≤ ψ
∗
i (i = 1, . . . ,m), (4.46b)
that is, each criterion target i is set to ψ∗i .
Proposition 4.16 (COST solution from CRIT). Let r∗ and the Lagrange multiplier λφ solve
Problem 4.45. Then, r∗ also solves Problem 4.46 with the optimal objective φ(r∗) = B.
The optimal Lagrange multipliers for Problem 4.46 satisfy λ∗ = λˆ∗ ∈ Rm++ and
{λ∗1, . . . , λ
∗
m} = {
λφ
h1
, . . . ,
λφ
hm
}. (4.47)
All the criterion constraints in (4.46b) are strongly active at r∗.
Proof First, we note that λφ > 0 and φ(r∗) = B by Proposition 4.12. Condition (ii) of
Proposition 4.12 for Problem 4.45 is
∇jL(r
∗, λφ) = ∇j
( m∑
i=1
hiψi(r
∗) + λφφ(r∗)
)
≥ 0, (4.48)
which is equivalent to
∇j
(
φ(r∗) +
m∑
i=1
hi
λφ
ψi(r
∗)
)
≥ 0. (4.49)
By definition of criterion constraints (4.46b), r∗ is feasible for Problem 4.46. By Proposi-
tion 4.4, condition (4.49) is necessary and sufficient for r∗ and λ∗ in (4.47) to solve Problem
4.46. 
Conversely, we could solve Problem 4.46 first and use r∗ to solve Problem 4.45.
Compound φ(r) in COST Problem
Let COST Problem be specified as
minimize
r∈P+
φ(r) =
q∑
k=1
vkφk(r) (4.50a)
subject to ψ(r) ≤ c, (4.50b)
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where c ∈ rngψ and vk > 0 for k = 1, . . . , q. Let r∗ solve this problem with φ∗k = φk(r∗)
for k = 1, . . . , q. Suppose CRIT Problem is specified as
minimize
r∈P+
ψ(r) (4.51a)
subject to φk(r) ≤ φ
∗
k (k = 1, . . . , q) (4.51b)
Proposition 4.17 (CRIT solution from COST ). Let r∗ and the Lagrange multiplier λψ
solve Problem 4.50. Then, r∗ also solves Problem 4.51 with ψ(r∗) = c. The optimal
Lagrange multipliers for Problem 4.51 satisfy λ∗ = λˆ∗ ∈ Rq++ and
{λ∗1, . . . , λ
∗
q} = {
v1
λψ
, . . . ,
vk
λψ
}. (4.52)
All the constraints in (4.51b) are strongly active at r∗.
Other cases
Suppose COST Problem 4.4 with several criterion constraints is solved by r∗ and λ∗ ∈
R
m
+ . If m ≥ 2, some λ∗i in λ∗ can be zero. Thus, compound criterion function (4.45a) in
equivalent CRIT Problem is defined with
λˆ
∗
= (λ∗1, . . . , λ
∗
mˆ)
T , (λˆ
∗
∈ Rmˆ++, mˆ ∈ {1, . . . ,m}), (4.53)
the Lagrange multipliers for the strongly active criterion constraints. We do not generally
know beforehand which criterion constraints will be strongly active at r∗. Thus, an equi-
valent CRIT problem can only be constructed once COST Problem 4.4 is solved. Similarly,
CRIT Problem 4.2 with several cost constraints has to be solved first before an equivalent
COST problem can be specified.
The following case is more straightforward.
Proposition 4.18 (Single constraints). Let CRIT Problem
minimize
r∈P+
ψ(r) s. t. φ(r) ≤ B, (4.54)
where B > 0, be solved by λφ and r∗ such that ψ∗ = ψ(r∗). Then r∗ solves COST Problem
minimize
r∈P+
φ(r) s. t. ψ(r) ≤ ψ∗, (4.55)
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with φ(r∗) = B and the optimal Lagrange multiplier
λψ =
1
λφ
, (4.56)
where (λψ, λφ)T ∈ R2++. Conversely, a solution to Problem 4.54 can be obtained from that
to Problem 4.55.
This result is particularly useful if there is also equivalence over design measures, as con-
sidered in Section 3.5.3.
4.5.4 LOSS Problem
Problem 4.5 (LOSS design).
minimize
r∈P+
L(r) = ψ(r) + µφ(r), (4.57)
where P+ = P ∩ Rn+, and µ > 0 is fixed.
Since both ψ(r) and φ(r) are convex and differentiable, so is their positive combina-
tion L(r). The optimisation domain is domL(r) = domψ(r) ∩ domφ(r) = P. The
problem is a special case of convex Problem A.2. Thus, solution can proceed by simple
non-Lagrangian methods. Since P+ is not compact, the Weierstrass Theorem A.1 does not
apply, and we generally need to assume that a solution exists.
From Proposition A.2 we have:
Proposition 4.19. If a solution to Problem 4.5 exists, then some r∗ ∈ P+ is such a solution
iff the derivative of L(r) with respect to rj satisfies
∇jL(r
∗) = ∇j
(
ψ(r∗) + µφ(r∗)
)
≥ 0 (∀j), (4.58)
with ∇jL(r∗) = 0 if r∗j > 0, where j = 1, . . . , n.
Essentially, the objective L(r) and condition (4.58) are the Lagrangian and the optimality
condition, respectively, for CRIT Problem in 4.54. Since Problem 4.54 has a solution r∗
and some unique λ∗ > 0, by Proposition 4.12, we could sometimes ensure that a solution
to Problem 4.5 exists as well.
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4.6 CRIT designs
We now consider some special cases of CRIT Problem 4.2 under assumption of the D-
criterion.
Linear costs
Problem 4.6 (Several linear costs).
minimize
r∈P+
ψ(r) = − ln |G(r)| (4.59a)
subject to φk(r) = γ
T
k r ≤ Bk (k = 1, . . . , q), (4.59b)
where Bk > 0 and γk ∈ Rn++ for k = 1, . . . , q, and q ∈ Z++.
The Lagrangian function is
L(r,λ) = − ln |G(r)|+
q∑
k=1
λk(γ
T
k r −Bk), (4.60)
where λ ∈ Rq+ and r ∈ P. The optimality condition in Proposition 4.12 states that
∇jL(r
∗,λ∗) =
q∑
k=1
λ∗kγkj − tr
{
G−1(r∗)gj
}
≥ 0 (∀j), (4.61)
with ∇jL(r∗,λ∗) = 0 if r∗j > 0.
Proposition 4.20. The vector λ∗ ∈ Rq+ of optimal Lagrange multipliers in Problem 4.6
satisfies ∑qk=1λ∗kBk = p, where p is the number of model parameters.
Proof The derivative ∇jL(r∗,λ∗) multiplied by r∗j ≥ 0 is
∇jL(r
∗,λ∗) r∗j =
q∑
k=1
λ∗kγkjr
∗
j − r
∗
j tr
{
G−1(r∗)gj
}
= 0 (r∗j ≥ 0), (4.62)
as item (ii) implies that if r∗j > 0, then ∇jL(r∗,λ∗) = 0, whereas if∇jL(r∗,λ∗) > 0 then
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r∗j = 0. The sum of all these n expressions (4.62) satisfies
n∑
j=1
∇jL(r
∗,λ∗) r∗j (4.63)
=
q∑
k=1
λ∗k
n∑
j=1
γkjr
∗
j −
n∑
j=1
r∗j tr
{
G−1(r∗)gj
}
=
q∑
k=1
λ∗kγ
T
k r
∗ − p =
q∑
k=1
λ∗kBk − p = 0,
from Propositions 4.7 and 4.12. 
Problem 4.7 (One linear cost).
minimize
r∈P+
ψ(r) = − ln |G(r)| (4.64a)
subject to φ(r) = γTr ≤ B, (4.64b)
where B > 0 and γj > 0 for j = 1, . . . , n.
As shown next, this problem does not require Lagrangian methods.
Proposition 4.21. (i) Problem 4.7 is equivalent to
minimize
r∈P+
f0(r) = − ln |G(r)|+
p
B
γTr. (4.65)
That is, both problems are solved by r∗ such that φ(r∗) = B.
(ii) The necessary and sufficient condition for the optimality of a feasible r∗ in Prob-
lem 4.7 is
∇jf0(r
∗) =
p
B
γj − tr
{
G−1(r∗)gj
}
≥ 0 (∀j), (4.66)
with ∇jf0(r∗) = 0 if r∗j > 0.
Proof Lagrangian for Problem 4.7 is
L(r, λ) = − ln |G(r)|+ λ(γTr −B) (r ∈ P, λ ≥ 0), (4.67)
with the optimality condition
∇jL(r
∗, λ∗) = λ∗γj − tr
{
G−1(r∗)gj
}
≥ 0 (∀j). (4.68)
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By Proposition 4.12, the Lagrange multiplier λ∗ is positive, bounded and unique. Propos-
ition 4.20 implies λ∗ = p/B. The substitution of λ∗ = p/B into (4.67) and (4.68) shows
items (i) and (ii), respectively. 
We note that f0(r) in (4.65) is essentially the objective function in LOSS Problem.
minimize
r∈P+
L(r) = − ln |G(r)|+ µγT r (4.69)
where µ > 0 is set to µ = λ∗ = p/B.
Nonlinear costs
Problem 4.8 (Quadratic cost).
minimize
r∈P+
ψ(r) = − ln |G(r)| (4.70a)
subject to γTr + ν(1Tr)2 ≤ B (4.70b)
where B > 0, ν > 0 and γj ≥ 0 for j = 1, . . . , n.
The Lagrangian is defined as
L(r, λ) = − ln |G(r)|+ λ(γTr + ν(1Tr)2 −B) (r ∈ P, λ ≥ 0), (4.71)
with the optimality condition
∇jL(r
∗, λ∗) = λ∗(γj + 2νN
∗)− tr
{
G−1(r∗)gj
}
≥ 0 (∀j) (4.72)
with∇jL(r∗, λ∗) = 0 if r∗j > 0. The budget constraint is strongly active; thus
∑n
j=1 γjr
∗
j+
ν(N∗)2 = B.
Proposition 4.22. The Lagrange multiplier λ∗ > 0 in Problem 4.7 is bounded and unique;
moreover,
λ∗ =
p
B + ν(N∗)2
. (4.73)
Proof We have
∇jL(r
∗, λ∗) r∗j = λ
∗(γjr
∗
j + 2νN
∗r∗j )− r
∗
j tr
{
G−1(r∗)gj
}
= 0 (r∗j ≥ 0). (4.74)
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The sum of all these n expressions satisfies
n∑
j=1
∇jL(r
∗, λ∗) r∗j (4.75)
= λ∗

 n∑
j=1
γjr
∗
j + 2νN
∗
n∑
j=1
r∗j

−
n∑
j=1
r∗j tr
{
G−1(r∗)gj
}
= λ∗

 n∑
j=1
γjr
∗
j + 2ν(N
∗)2

− p
= λ∗(B + ν(N∗)2)− p = 0,
from Proposition 4.7. 
Since N∗ is not known and thus λ∗ cannot be computed (from Proposition 4.22) before
optimisation, we have to retain the budget constraint in solving Problem 4.8, unlike with
CRIT Problem 4.7. Also, even though φ(r∗) = B at a solution, we can not set the budget
constraint to an equality since φ(r) is nonlinear, and the problem may become non-convex
(Avriel (1976), p. 95).
However, we can obtain results for some special cases. For instance, if γj = γ > 0 for
j = 1, . . . , n, then we have
∑
γr∗j + ν
(∑
r∗j
)2
= γN∗ + v(N∗)2 = B, (4.76)
at the problem solution. Thus, we solve this quadratic for N∗ > 0 to obtain
N∗ =
√
γ2 + 4νB − γ
2ν
. (4.77)
If all γj = 0, then we simply have N∗ =
√
B/ν. In either case, the value of λ∗ can be com-
puted, from (4.73), and substituted into (4.71). Then, Problem 4.8 reduces to unconstrained
minimisation, similar to that characterised in Proposition 4.21 for Problem 4.7.
As now illustrated, the Lagrangian derivative ∇jL(r∗, λ∗) can be plotted over X, or X
in our case, to verify the optimality of some design solution.
Example 4.2 (CYP2C19/S-Mephenytoin, continued).
Recall that quadratic cost
φ(r) = 1.471Tr + 0.0441xTr +
(
1Tr
)2
, (4.78)
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Fig. 4.2: Derivative of the optimal Lagrangian (4.72) evaluated for (4.79), in ( ), and for (4.80),
in ( ); support points shown in (•).
was minimised subject to Ψ(M(̺)) ≤ 818, 015.4 by COST-optimal design

23.6295 250.4703
1.2040 0.4421

 , (4.79)
with N = 1.646 and φ(̺∗) = 11.266. We use the equivalence, characterised by Proposition
3.4, of this COST problem with CRIT Problem 4.8 subject to φ(r) ≤ 11.266, where the
cost is (4.78). Thus, we compute optimal Lagrange multiplier (4.73) as λ∗ = 2/(11.266 +
1.6462) = 0.1431. The Lagrangian derivative in (4.72) is evaluated at (4.79) over X and
plotted in Figure 4.2.
The COST-optimal design minimising (4.78) subject to Ψ(M(̺)) ≤ 81, 801.54 is

26.4248 320.7078
3.0739 1.4572

 . (4.80)
The corresponding optimal Lagrange multiplier is λ∗ = 0.0278; see Figure 4.2 for a plot. 
4.7 COST designs
We now consider two special cases of COST Problem 4.4 under the linear cost.
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Problem 4.9 (D-criterion).
minimize
r∈P+
φ(r) = γTr (4.81a)
subject to ψ(r) = − ln |G(r)| ≤ c, (4.81b)
where c ∈ R.
The Lagrangian function is
L(r, λ) = γTr + λ(− ln |G(r)| − c), (4.82)
where λ ≥ 0 and r ∈ P. The optimality condition in Proposition 4.15 is
∇jL(r
∗, λ∗) = γj − λ
∗tr
{
G−1(r∗)gj
}
≥ 0 (∀j), (4.83)
with ∇jL(r∗, λ∗) = 0 if r∗j > 0.
Proposition 4.23. If r∗ and λ∗ solve Problem 4.9 then
λ∗ =
γTr∗
p
, (4.84)
where p is the number of model parameters.
Proof Let φ∗ = γTr∗. By Proposition 4.18, Problem 4.9 is equivalent to
minimize
r∈P+
− ln |G(r)| s. t. γTr ≤ φ∗, (4.85)
which is solved by r∗ and some Lagrange multiplier λφ > 0. Also, λ∗ = 1/λφ by the same
proposition, whereas Proposition 4.20 implies λφ = p/φ∗. 
Unlike with CRIT Problem 4.7, the optimal φ∗ and λ∗ for Problem 4.9 are unknown, and
direct solution of this problem requires Lagrangian methods. A more efficient approach is
to solve Problem 4.7 and normalise its solution to w∗. Then, a solution to Problem 4.9 is
obtained as r∗ = κw∗ where
κ = exp(−c)|G(w∗)|−1/p. (4.86)
We now assume that p ≥ 2.
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Problem 4.10 (A-criterion and D-criterion).
minimize
r∈P+
φ(r) = γTr (4.87a)
subject to ψ1(r) = − ln |G(r)| ≤ c1, (4.87b)
ψ2(r) = trG
−1(r) ≤ c2, (4.87c)
where c1 ∈ (−∞,∞) and c2 ∈ (0,∞).
The Lagrangian function is
L(r,λ) = γTr + λ1(− ln |G(r)| − c1) + λ2(trG
−1(r)− c2), (4.88)
where λ ∈ R2+ and r ∈ P. The optimality condition in Proposition 4.15 is
∇jL(r
∗,λ∗) = γj − λ
∗
1tr
{
G−1(r∗)gj
}
− λ∗2tr
{
G−2(r∗)gj
}
≥ 0 (∀j), (4.89)
with∇jL(r∗,λ∗) = 0 if r∗j > 0. If both constraints are active at r∗ we cannot automatically
solve Problem 4.10 via design measures.
4.8 Related results
Optimisation over fixed design points is applied in Titterington (1976); Torsney and Alahmadi
(1992); and Torsney and Martı´n-Martı´n (2009) to design measures. Constrained designs
over ω were considered, eg, in Cook and Fedorov (1995); Fedorov and Hackl (1997)
Chapter 4; Lee (1987, 1988); Cook and Wong (1994); and Clyde and Chaloner (1996).
The latter two references presented results on design equivalences.
An extensive search of design literature in English has produced only a few references
with relaxed designs. The following discussion applies the terminology and notation as
defined in this thesis. (The term ‘relaxed design’ was not used in those references.)
Molchanov and Zuev (2000, 2001) applied relaxed designs, and more generally signed
measures, to the design of experiments with linear response models. A similarity with their
approach is that the methods in this chapter allow negative replications. The general design
problem in Section 1 of Molchanov and Zuev (2001) is not dissimilar to CRIT Problem
4.2. (In fact, Molchanov and Zuev (2001) also allowed equality constraints.) Formulations
similar to COST Problem or MIXED Problem were not considered. The constraint µ(X) =
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1, where µ denotes a signed measure, was imposed in design problems, which somewhat
brings us back to standard optimal design over ω. Only linear constraints were considered
in the design problems with multiple constraints. A finite X was not required in theoretic
developments, but was considered in the context of numerical algorithms. The authors also
developed a steepest descent algorithm for optimal design over signed measures.
Sagnol (2011) considered c-optimal designs (defined in Atkinson et al., 2007, p. 142)
for linear multi-response models. Relaxed designs defined over some fixedX were formally
applied in Theorems 3.3, 4.3 and 5.1 of the article. Several problems of second-order cone
programming (SOCP) were formally defined with relaxed designs to provide duals for c-
optimal design problems. Those SOCP problems were not unlike COST Problem with
φ(̺) = 1Tr as the objective. The constraints in Sagnol (2011) were defined as matrix
equalities or inequalities. Relaxed designs were not pursued beyond the purely technical
settings.
Rafajlowicz (1989) developed a framework, related to COST Problem 4.4, for exper-
iments with linear response models. The experimenter specified a matrix A ∈ Sp++ with
some desirable properties and defined a single constraint M(̺) = A. A design solution
̺∗ minimised a linear φ(̺) among all relaxed designs such that M(̺) = A. Lagrangian
approach, negative replications or fixed design points were not considered. The existence
of solutions was assumed without a proof.
Incidently, the approaches in Rafajlowicz (1989) and Sagnol (2011) could have the
following extension, applicable to experiments with a linear or nonlinear η(x,θ). Suppose
that the experimenter seeks to improve upon some traditional design rich, which provides
satisfactory information but is expensive.
The following problem can be defined.
Problem 4.11 (COST with a matrix constraint).
minimize
r∈P+
φ(r) (4.90a)
subject to G(r) ≥ B(rich), (4.90b)
where B(rich) ∈ Sp++ is the information matrix of rich.
Suppose that the problem is defined over some fixedX which includes supp rich. Then, the
problem is feasible: in the worst case the solution is rich itself. Hopefully, a cheaper design
4. Relaxed designs 82
with G(r∗) ≥ B(rich) could be found. If φ(r) is convex and differentiable, Problem 4.11
can be solved by convex methods of semi-definite programming (eg, Boyd and Vanden-
berghe, 2004, Chapter 11). A potential advantage of this formulation is that information
criteria need not be selected.
5. COMPROMISE DESIGNS
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A key purpose of compromise designs is to accommodate hard-to-quantify practical
requirements while maximally preserving the benefits of optimal designs. The chapter
presents an approach to compromise designs which builds upon the design methods de-
veloped in previous chapters.
5.1 Enzyme inhibition experiment
This section presents a hypothetical experiment used in design examples later in this chapter.
This experiment is modelled after an enzyme inhibition study described in Youdim et al.
(2010) and Bogacka et al. (2011), which was performed at a standard rich design.
The experiment investigates the metabolic rate of the substrate Dextrometorphan, which
is metabolised by CYP2D6, in the presence of the inhibitor Sertraline. The response is
modelled by the competitive inhibition model
η(x, u,θ) =
V x
K
(
1 +
u
Q
)
+ x
(
X ⊂ R2+
)
, (5.1)
where θ = (V ,K,Q)T ∈ R3++. The design factors are the substrate and inhibitor con-
centrations, whose levels are denoted by x and u, respectively. (See Section 2.2 for a
background and Figure 2.2 for a plot of (5.1).) Each factor combination (x, u) belongs
to X = [0, xmax]× [0, umax], where xmax > 0 and umax > 0.
We assume (5.1) with
X = [0, 30] × [0, 60], (K∗, V ∗, Q∗)T = (1.0, 4.4, 2.6)T , (5.2)
and consider design of experiments that confirm this θ∗. Other statistical assumptions, in
Chapter 2, are also made: in particular, that observation errors satisfy e ∼ N (0, IN ), where
σ2 ≡ 1 is set for convenience. (Youdim et al., 2010 and Bogacka et al., 2011 contain a
background and several results relevant to this problem.)
A relaxed design for this experiment is defined as
̺ =

(x1, u1) . . . (xn, un)
r1 . . . rn

 (r ∈ Rn+), (5.3)
where each (xj , uj) ∈ X is distinct for j = 1, . . . , n. Thus, ̺ could contain (x1, u1) and
(x2, u2) such that x1 = x2, provided u1 6= u2. According to the approach in Chapter 4
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Fig. 5.1: Support points of the rich design.
each (xj , uj) is the element j of some fixed X . Our general discussion retains the notation
xj for a design point, with the implication that it could be a vector.
We assume that the rich design for this experiment contains every combination of the
fifteen substrate concentrations with the eight inhibitor concentrations:
x ∈{0.01, 0.025, 0.03, 0.083, 0.1, 0.25, 0.3, 0.83, 1, 2.5, 3, 8.33, 10, 25, 30} (5.4)
u ∈{0.0, 0.95, 1.9, 3.75, 7.5, 15, 30, 60},
so that there are n = 15× 8 = 120 support points; see Figure 5.1. The assumed rich design
is
rich =

(0.01, 0) (0.01, 0.95) . . . (30, 15) (30, 30) (30, 60)
2 2 . . . 2 2 2

 , (5.5)
where each (xj , uj) is replicated twice for j = 1, . . . , 120, so that N = 240. This design is
similar to the rich design in Youdim et al. (2010) and Bogacka et al. (2011); cf. Figure 1 of
Bogacka et al. (2011) of the latter paper; although the latter design had one replication per
design point and 120 replications in total.
The experimental costs were extrapolated from the costs of another enzyme kinetics
study, without an inhibitor. This study is described in Volkov et al. (2008), which was co-
written with project participants from Pfizer UK, who also provided empirical estimates of
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experimental costs. As detailed in Section B.2, the extrapolated cost, in £, is
φ(r) = 1.471Tr + 0.0156xTr + 0.0061uTr, (5.6)
which is a linear function of replications, with γj = 1.47 + 0.0156xj +0.0061uj being the
positive cost per observation at (xj , uj). This assumed φ(r) puts the cost of (5.5) at about
£395, which is comparable to £216, the cost of the experiment in Volkov et al. (2008).
5.2 Targets and penalty functions
To obtain compromise designs we first specify some X with n ≥ p(p+ 1)/2 design points
xj ∈ X . This X could be set to the support points of some desirable design: eg, a rich
design; a design optimal for another problem; a central composite design or another design
used in response surface methodology. Alternatively, X could combine the support points
of several designs or be selected otherwise. Throughout we assume that X is fixed and the
corresponding M is proper, according to Assumption 4.1.
Next, we select some vector τ ∈ Rn+ as the targets for replications r ∈ Rn over X .
Each τj ≥ 0 in τ is the target for the replication rj of some xj ∈ X for j = 1, . . . , n. If
some design is used to define X then τ can be set to the replications of this design. If
a replication at xj ∈ X is undesirable but possible then τj = 0 is set. If targeting rj is
unnecessary then any τj ≥ 0 is set. It is convenient, but not strictly necessary, to use a
nondegenerate τ whose G(τ ) ∈ Sp++.
A penalty function ̟ : Rn → R is used to ‘discourage’ the deviation of r from τ . The
quadratic ̟(r) is defined as
̟(r) =
n∑
j=1
βj(τj − rj)
2 = βT (τ − r)2
(
β ∈ Rn+, β 6= 0, τ ∈ R
n
+, τ 6= 0
)
, (5.7)
where each constant βj ≥ 0 reflects the importance of targeting rj . If βj = 0 then rj
need not be targeted, and the value τj is irrelevant. For notational simplicity τj ≥ 0 is
assumed even if βj = 0. Note that if τ = 0 and β ∈ Rn++ then (5.7) becomes similar to
quadratic cost (3.29). There is also a similarity between (5.7) and weighted squared-loss
functions used in the utility-based approach to parameter estimation; see Berger (1985),
Chapter 2.4.2; and Robert (2007), Chapter 2.5.
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Fig. 5.2: The target τ = 5 is in ( ). The penalty (τ − r)2, in ( ), penalises |τ − r| ∈ (0, 1)
more than (τ − r)10, in ( ), does. The situation is reversed if |τ − r| > 1.
Penalty (5.7) is generalised by
̟(r) = βT (τ − r)α
(
α ∈ {2, 4, 6, . . .}
)
, (5.8)
where β, τ and r are as in (5.7), and α is a positive even integer. Particular values of α
could help achieve different goals, as illustrated in Figure 5.2 and explored in Section 5.4.
(A large α may cause ill-conditioning and overflow in numerical implementations.) Other
̟(r) could be specified as required.
We assume that any ̟(r) satisfies the following definition, which holds for (5.8):
Definition 5.1. Let some X with n design points be fixed. A penalty function ̟ : Rn → R
penalises deviations of replications r ∈ Rn, over X , from their targets τ ∈ Rn+ where
τ 6= 0. The function ̟(r)
(i) has rng̟ = [0,∞);
(ii) is non-decreasing for every j and increasing at least for one j, where j = 1, . . . , n;
(iii) is convex and differentiable over Rn;
(iv) achieves its minimum over Rn of ̟(r) = 0 if and only if r = τ .
5.3 Design approach
Preliminary stage The implemented approach takes COST Problem 4.4 as its starting
point; an alternative based on CRIT Problem 4.2 is noted in Section 5.5. We assume that a
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single linear cost φ(r) = γTr is specified. Also, m ∈ Z++ criterion constraints ψi(r) ≤ ci
are provided, whose targets are set as ci = ψi
(
G(τ )
)
or selected otherwise. We next solve
Problem 5.1 (COST).
minimize
r∈P+
γTr (5.9a)
subject to ψi(r) ≤ ci (i = 1, . . . ,m), (5.9b)
where P+ ⊂ Rn, γ ∈ Rn++ and ci ∈ rngψi for i = 1, . . . ,m.
This is just Problem 4.4 in Section 4.5. From now r∗ shall denote a solution to some
instance of Problem 5.1 and φ∗ = γTr∗, the cost of r∗.
Let φτ = γTτ , with φτ > 0 since τ ∈ Rn+ and τ 6= 0. For the moment, suppose that τ
is feasible for Problem 5.1, in which case φτ ≥ φ∗. If φτ = φ∗ then τ solves Problem 5.1
and should be chosen for the experiment. Likewise, a feasible τ is chosen if savings from
r∗ are deemed insignificant.
Search for compromise designs As a rule, a compromise design must forgo some savings
from r∗ to gain some desirable features of τ . To find a compromise design, r⋆, we select
some provisional budget B⋆ > φ∗ for the experiment and solve
Problem 5.2 (MIXED).
minimize
r∈P+
̟(r) (5.10a)
subject to γTr ≤ B⋆ (5.10b)
ψi(r) ≤ ci (i = 1, . . . ,m). (5.10c)
The objective ̟(r) satisfies Definition 5.1. Constraint (5.10b) is defined with cost function
(5.9a) and some B⋆ > φ∗, where φ∗ is the cost of r∗ solving Problem 5.1. Constraints
(5.10c) are identical to (5.9b).
This problem is convex and differentiable, and its feasible set is
Ω = Rn+ ∩ Γ
m⋂
i=1
Υi, (5.11)
where Γ = {r ∈ Rn |γTr ≤ B⋆}, and each Υi = {r ∈ P |ψi(r) ≤ ci} with ci ∈ rngψi.
Any r∗ that solves Problem 5.1 is feasible for Problem 5.2.
5. Compromise designs 89
Problem 5.2 is associated with the Lagrangian L : P× Rm+1+ → R defined as
L(r,λ) = ̟(r) + λ0(γ
Tr −B⋆) +
m∑
i=1
λi(ψi(r)− ci), (5.12)
where r ∈ P and λ ∈ Rm+1+ .
Proposition 5.1. A solution to Problem 5.2 exists and is verified by Karush-Kuhn-Tucker
Theorem A.4. Some r⋆ ∈ Ω is a solution if and only if there exists λ⋆ ∈ Rm+1+ such that
∇jL(r
⋆,λ⋆) = λ⋆0γj +∇j
(
̟(r⋆) +
m∑
i=1
λ⋆iψi(r
⋆)
)
≥ 0 (∀j), (5.13)
with ∇jL(r⋆,λ⋆) = 0 if r⋆j > 0.
Proof The compactness of Ω can be shown as for COST Problem 4.3. That Problem 5.2
is strictly feasible, according to Definition A.9, is shown as follows. Let κ = B⋆/φ∗,
with κ > 1 since B⋆ > φ∗. Then κr∗ ∈ P+ satisfies G(κr∗) = κG(r∗) > G(r∗).
Since r∗ ∈ Ω property (ii) in Definition 4.7 of ψ(r) implies ψi(κr∗) < ψi(r∗) ≤ ci
for i = 1, . . . ,m. Since constraint (5.10b) is linear, φ(κr∗) = κγT r∗ = B⋆ suffices for
Definition A.9. All the assumptions in Karush-Kuhn-Tucker Theorem A.4 therefore hold.
Expression (5.13) applies the optimality conditions of Theorem A.4. 
Problem 5.1 could be solved by some r† 6= r∗ such that φ(r†) = φ∗ and ̟(r†) < ̟(r∗).
If, however, B⋆ = φ∗ is allowed in Problem 5.2, the problem is still feasible but not strictly
so, and our optimisation approach no longer applies.
Instead of a single B⋆, we could specify several provisional budgets B⋆ℓ , such that φ∗ <
B⋆ℓ < B
⋆
ℓ+1 for ℓ = 1, . . . , ℓmax and ℓmax ∈ Z++. Each B⋆ℓ defines Instance ℓ of MIXED
Problem 5.2 whose solution is some r⋆ℓ . The following properties are intuitive:
• If B⋆ℓ+1 > B⋆ℓ then ̟(r⋆ℓ+1) ≤ ̟(r⋆ℓ): that is, r⋆ℓ+1 cannot get farther away from τ
but might get closer to it, if the budget is increased.
• If τ is feasible for Instance ℓ then r⋆ = τ and ̟(r⋆) = 0: that is, ̟(r) achieves
its global unconstrained minimum over Rn. Since B⋆ℓ ≥ φτ by feasibility of τ , any
instance defined with B⋆ℓ+1 > B⋆ℓ is solved by r⋆ℓ+1 = τ .
• Suppose τ is nondegenerate, and the criterion targets in (5.10c) are ci = ψi
(
G(τ )
)
for i = 1, . . . ,m. The previous condition implies that instances with B⋆ℓ ≥ φτ need
not be considered.
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Fig. 5.3: Replications in r∗ shown as •, and in r† as ©; contours of (5.16) shown over a fine grid.
5.4 Design example
Compromise designs are illustrated for the experiment in Section 5.1. We assume cost (5.6)
and the D-criterion function ψ(r) = − ln |G(r)|. The standard rich, chosen as the target
design, has φ(rich) = £394.93, c = ψ(rich) = 3.236 and rj = 2 for j = 1, . . . , 120. We
set X = supp rich and τ = 2, and solve
Problem 5.3 (COST).
minimize
r∈P+
γTr (5.14a)
subject to − ln |G(r)| ≤ 3.236. (5.14b)
The solution, obtained in MatLab, is
r∗ =

(3.0, 0) (30.0, 0) (25.0, 15.0)
19.08 14.94 14.83

 , (5.15)
with N = 48.85 and φ(r∗) = £86.84. To verify r∗ the Lagrangian derivative
∇jL(r
∗,λ∗) = γj − λ
∗tr
{
G−1(r∗)gj
}
, (5.16)
was evaluated at r∗ over a fine grid covering X = [0, 30] × [0, 60]; see Figure 5.3. The
minimum value of (5.16) was−0.0185. Problem 5.3 was solved over this fine grid to obtain
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x u £100 £95 £95† £93 £91 £91† £89 £87‡
1.0 0 0.63
2.5 0 6.42 7.35 6.76 7.71 8.14 8.09 8.37
2.5 0.95 0.52
3 0 6.84 7.96 6.91 8.47 9.21 8.36 10.20 19.08
3 0.95 1.01 0.03
8.33 0 2.63 2.23 4.35 1.83 0.98 1.08
8.33 3.75 0.53
8.33 7.5 1.32 0.85 0.30
10 0 1.84 1.16 0.06 0.60
10 3.75 0.37
10 7.5 1.86 1.68 0.38 1.38 0.70
10 15 0.60
25 0 4.54 5.01 5.62 5.29 5.48 6.84 5.04
25 0.95 1.43 0.68 0.01
25 7.5 1.36 1.00 0.65
25 15 3.86 4.59 5.37 5.07 5.76 6.33 6.93 14.83
25 30 2.33 2.16 2.18 1.90 1.29
30 0 6.08 7.15 6.35 7.85 8.74 7.94 10.38 14.94
30 0.95 2.89 2.69 4.32 2.42 1.48 0.94
30 1.9 1.09 0.21
30 7.5 0.98 0.38
30 15 3.69 4.33 5.24 4.76 5.32 6.08 6.00
30 30 3.17 3.41 4.67 3.48 3.46 4.59 2.69
N 56.0 52.9 52.2 51.7 50.6 50.3 49.6 48.9
n∗ 23 18 12 15 11 9 7 3
Tab. 5.1: Compromise designs were found under quadratic ̟(r) except: †found quartic ̟(r);
‡optimal r∗; n∗ is the number of support points in a design.
some Lagrange multipliers λ† and
r† =

(3.3, 0) (30.0, 0) (28.8, 18.6)
18.94 14.86 14.17

 , (5.17)
with min∇jL(r†,λ†) = −0.00005 ≈ 0. Since φ(r†) = 86.42 ≈ φ(r∗) = 86.84 we
conclude that r∗ in (5.15) and the assumed X are adequate.
Instance ℓ of Problem 5.2 is
Problem 5.4 (MIXED ℓ).
minimize
r∈P+
̟(r) = (τ − r)2 (5.18a)
subject to γTr ≤ B⋆ℓ (5.18b)
− ln |G(r)| ≤ 3.236, (5.18c)
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where τ = 2, φ(r) = γTr in (5.6), B⋆ℓ ∈ (86.84, 394.93), and X = supp rich.
Several instances of this problem were solved in MatLab; Table 3.1, and Figures 5.4 and 5.5
display some of the solutions. Every r⋆ℓ found satisfied ψ(r⋆ℓ) = 3.236 and φ(r⋆ℓ ) = B⋆ℓ .
As expected, replications in each subsequent r⋆ℓ+1 were added to the regions corresponding
to the valleys in Figure 5.3. Solutions to Problem 5.4 found under ̟(r) = (τ − r)4 had
fewer support points but more uniform replications than the solutions under the quadratic
̟(r); see Figure 5.5. These differences were more pronounced for B⋆ℓ ∈ [90, 100] and
rather diminished for larger B⋆ℓ . Although these patterns may be an artefact of the specific
numerical example, the availability of different penalty functions may be generally helpful.
In this example, compromise designs have achieved their intended goals. For instance,
Figure 5.4 suggests that r⋆ℓ costing £93, just £6 over φ∗, is noticeably more similar to rich
than r∗ is. The compromise design for B⋆ℓ = £175 contains all the n = 120 support points
of rich, with the two designs being rather alike, despite the cost difference.
5.5 Some extensions
Potential extensions of the compromise design approach are as follows.
• The initial choice of τ could be influenced by r∗ obtained in COST Problem 5.1. If
τ is more similar to r∗ then a more efficient r⋆ℓ might be found for a given B⋆ℓ . For
instance, r∗ in the top panel of Figure 5.4 suggests a possible removal from X of all
the support points with uj = 60.
• The initial r∗ could be obtained from CRIT Problem 4.2. Then, a single ψ(r) would
be specified along with the cost constraints γTk r ≤ Bk where k = 1, . . . , q. Each
Instance ℓ of MIXED Problem would have a different target cℓ ∈ rngψ and the
same cost constraints γTk r ≤ Bk. Naturally, there could be equivalences between
this approach and that in Section 5.3.
• Both ̟(r) and τ could be adapted between instances of MIXED Problem 5.4.
• Various functions ̟(r) could be introduced into compromise design.
• A potential technical application, suggested by Figure 5.5, is to incorporate a suitable
̟(r) into algorithms for rounding non-integer replications in optimal designs.
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Fig. 5.4: Compromise designs under a quadratic penalty. Each (◦) is rj in rich for j = (1, . . . , 120),
with φ(rich) ≈ £395 and ψ(rich) = 3.236. (•) is a replication in r∗ (top panel)
or in r⋆ℓ (other panels). Marker size ∝ the weight of a design point; some mark-
ers overlap. The criterion value at every design equals 3.236. From top to bottom:
N = 48.9, 49.6, 51.7, 56.0, 103.6, and n∗ = 3, 7, 15, 23, 120.
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Fig. 5.5: Quadratic vs. quartic penalties. Each (•) ∝ weight of xj in r⋆ℓ . Top: N = 50.6, 50.3 and
n∗ = 11, 9; bottom: N = 52.9, 52.2 and n∗ = 18, 12.
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Penalty function (5.8) can be extended as
̟(r) =
n∑
j=1
βj
∣∣τj − rj∣∣αj (τj ≥ 0, βj ≥ 0, αj ≥ 1), (5.19)
where | · | denotes the absolute value, with a distinct αj defined for each xj . This ̟(r)
has rng = [0,∞) and is convex (Boyd and Vandenberghe, 2004, p. 71), continuous and
attains its global minimum over Rn at |τ − r| = 0. In some cases (eg, if all αj = 1),
this ̟(r) is not differentiable at any r such that
∣∣τj − rj∣∣ = 0 for at least one j. Then,
more general techniques of convex optimisation would be required than those in the thesis.
Other possible ̟(r) include logarithmic penalty functions (such as log-barrier functions in
interior-point optimisation; Boyd and Vandenberghe (2004), Chapter 11) which could that
no τj is exceeded. Asymmetric penalty functions, in which rj < τj is penalised differently
from rj > τj , could also be implemented.
Rather than targeting each individual rj , we could target the total replications in a group
of design points. This could be useful if we seek r⋆ with a general structure of rich, but do
not wish to ‘micromanage’ every location xj ∈ supp rich. Another potential application
is to designs whose replications must be spread over particular regions in X, as required in
some experiments; eg, Sahm and Schwabe (2001); and Fedorov and Hackl (1997), Chapter
4.3.
Suppose that X contains n ≥ 2 design points which are allocated to groups , where
 = 1, . . . , ng and ng ∈ Z++. A given xj ∈ X is assigned to one or several distinct groups,
as illustrated in Figure 5.6, or to none at all. Each group  contains n ∈ {1, 2, . . . , n}
distinct design points, whose replications are r ∈ Rn . The replications total N = 1Tr
in group  is targeted by τ ≥ 0, with such a target defined for each  = 1, . . . , ng.
To find a compromise design we could generalise quadratic penalty (5.7) as
̟(r) =
ng∑
=1
β(τ − 1
Tr)
2 (r ∈ R
n , β ≥ 0, τ ≥ 0,∀), (5.20)
where the constant β reflects the importance of targeting N. Alternatively, we could target
the total cost φ(r) of the replications in group  and define
̟(r) =
ng∑
=1
β(τ − φ(r))
2, (5.21)
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where τ ≥ 0 is now the target budget. This approach could be extended to design of a
series of experiments, where a target budget is defined for each individual experiment.
5.6 Related results
Several ideas related to compromise designs have been considered in design literature. For
example, Bogacka et al. (2008) considered sampling window designs, which are exact,
that relinquished some efficiency of optimal designs so as to provide more convenience for
experimenters and subjects in a clinical trial. Similar design problems were considered in
Graham and Aarons (2006), and Pronzato (2002). Fedorov and Leonov (2005) suggested
to use local optimal designs as reference points for improvement of traditional designs of
pharmaceutical experiments. In Murphy et al. (2002, 2003) extra points were incorporated
into optimal designs to make them more practical.
The use of penalty functions in this thesis is similar to the application of “weight”
functions in Bowman and Woods (2013) to optimal design of computer simulation experi-
ments. These functions regulated the distances between the points in an exact design so as
to achieve appropriate “coverage” of interesting regions in X and “spread” of design points
over the design region.
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A. MATHEMATICAL BACKGROUND
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A regular1 and a bold lower case letter denotes a scalar and a vector, respectively. A
bold upper case letter denotes a matrix. The symbols Z+ and Z++ denote the sets of all
nonnegative and positive integers; R = (−∞,∞), R+ = [0,∞) and R++ = (0,∞)
denote all real, nonnegative and positive numbers. For some n ∈ Z++, Rn denotes the
n-dimensional Euclidean vector space; Rn+ and Rn++ denote the nonnegative and positive
orthant in Rn.
A.1 Sets, vectors and functions
The open ball B(a, ǫ) centred at a ∈ Rn with radius ǫ > 0 is the set of all r ∈ Rn such
that ‖a, r‖ < ǫ. Let S be a set in Rn and a a vector in S. The vector is an interior
point of S if there is ǫ > 0 such that B(a, ǫ) ⊂ S. The vector is a boundary point if every
B(a, ǫ) contains some vectors that belong to S and some that do not. A vector b in Rn, but
not necessarily in S, is a limit point of S if every B(b, ǫ) contains infinitely many r ∈ S
(Kolmogorov and Fomin (1975), p. 47). The set S is open if it only contains interior points.
The set is closed if its complement in Rn is open; or, equivalently, if S contains all its limit
points (Sundaram (1996), p. 22). The symbol intS denotes the interior of S, ie, the set
of all interior points in S, with intS = S if S is open. For instance, Rn is both open and
closed, Rn+ is closed, whereas Rn++, open. The set S is bounded if it is contained in some
open ball of a finite radius, and unbounded otherwise. Informally, a set S ⊂ Rn is compact
if it is both bounded and closed. For instance, any set containing finitely many elements is
compact.
Definition A.1. A set S 6= ∅ is convex if for any two its elements a and b and any γ ∈ [0, 1],
the element
c = γa+ (1− γ)b ∈ S, (A.1)
where c is a weighted combination of a and b.
Definition A.2. A set S 6= ∅ is a convex cone if for any two its elements a and b and any
α ≥ 0 and β ≥ 0 the element
c = αa+ βb ∈ S, (A.2)
where c is a nonnegative (or conic) combination of a and b.
Definition A.3 (Partial ordering of vectors). Let the vectors a and b belong to Rn. The
vector a is
1 Complete
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(i) greater than b, denoted a > b, if aj ≥ bj , j = 1, . . . , n, with at least one aj > bj;
(ii) strictly greater than b, denoted a >> b, if aj > bj , j = 1, . . . , n.
In the notation f : D → U the set D is the function domain, also denoted dom f , such
that f is defined at every element ofD. The symbol U denotes the function co-domain, such
that the function range, rngf satisfies, rngf ⊆ U .
Definition A.4 (Function monotonicity over a set). Let S ⊆ Rn be nonempty, and f : D →
U be a function whose domain D ⊆ Rn satisfies S ⊆ D and whose range rng f ⊆ U
is endowed with a (partial) order ≤. Also, let the vectors a and b belong to S. Then the
function over S is
Decreasing if f(a) ≤ f(b) whenever a > b, and f(a) < f(b) whenever a >> b;
Strictly decreasing if f(a) < f(b) whenever a > b;
(Strictly) increasing if −f(r), where r ∈ S, is (strictly) decreasing.
Definition A.5. Let a function f : D → U be such that rngf ⊆ U is endowed with a
(partial) order ≤. Then f is convex if dom f = D is a convex set and if for any elements
a and b in D,
f(γa+ (1− γ)b) ≤ γf(a) + (1− γ)f(b), (A.3)
where γ ∈ [0, 1].
(See, eg, Bernstein (2005), p. 282 for matrix-valued functions.) The function convexity is
preserved over any (nonempty) convex subset of D.
Let f : D → R and D ⊆ Rn. The partial derivative of f(r) with respect to the element
rj of r ∈ intD is defined as
∇jf(r) = lim
δ→0
f(r1, . . . , rj + δ, . . . , rn)− f(r1, . . . , rj , . . . , rn)
δ
. (A.4)
(We do not require derivatives at boundary points.) The function is differentiable (and
continuous) if the gradient vector
∇f(r) =
[
∇1f(r),∇2f(r), . . . ,∇nf(r)
]T
, (A.5)
exists at every r ∈ intD.
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A.2 Positive (semi)definite matrices
The symbol Sp denotes the set of all real symmetric p× p matrices; Sp+ ⊂ Sp, that of all
positive semidefinite matrices; and Sp++ ⊂ S
p
+, that of all positive definite matrices.
Definition A.6. A matrix A ∈ Sp is positive semidefinite if vTAv ≥ 0 for all v ∈ Rp and
is also positive definite if vTAv > 0 for every nonnull v. The matrix A is indefinite if
neither A nor −A is in Sp+.
Proposition A.1. If A ∈ Sp+ then its determinant satisfies |A| ≥ 0. Furthermore, A
satisfies either all the conditions in (i) or all the conditions in (ii) below:
(i) A ∈ Sp++; the inverse A−1 exists and A−1 ∈ Sp++; |A| > 0; the rank of A equals p;
all the eigenvalues of A are positive.
(ii) A /∈ Sp++; the inverse of A does not exists; |A| = 0; the rank of A is less than p; at
least one eigenvalue of A is zero.
(Horn and Johnson (1985), p. 14; Abadir and Magnus (2005), p. 216.) If A satisfies (i)
then it is nonsingular (or nondegenerate), and singular (or degenerate) otherwise.
For any A and B in Sp+, the matrix
αA+ βB ∈ Sp+ (α ≥ 0, β ≥ 0) (A.6)
also belongs to Sp+. In particular, κA ∈ S
p
+ for any κ ≥ 0 and hence 0 ∈ S
p
+. Therefore,
S
p
+ is a cone which is unbounded, convex and closed (see Pukelsheim (1993), Chapter 1.9
and Boyd and Vandenberghe (2004) Chapter 2.2 for details). Suppose now the A ∈ Sp++
and B ∈ Sp+. Then, the matrix
αA+ βB ∈ Sp++ (α > 0, β ≥ 0); (A.7)
in particular, κA ∈ Sp++ for any κ > 0, whereas neither 0 ∈ S
p
+ nor κB ∈ S
p
++ where
κ ≥ 0. The set Sp++ is convex, unbounded but, unlike S
p
+, open. Also, S
p
++ constitutes the
interior of Sp+ relative to Sp; Pukelsheim (1993) Chapter 1.9.
As any M ∈ Sp has p2 entries, only p˜ = p(p+ 1)/2 of which can be distinct, Sp is
isomorphic to Rp˜. Thus, each M ∈ Sp maps one-to-one to some vector v ∈ Rp˜ containing
p˜ distinct entries of M. The set Sp+ ⊂ Sp is isomorphic to a nonempty subset of Rp˜. The
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Fig. A.1: The boundary of S2+ comprises 2× 2 matrices of rank 1 and the 2× 2 zero matrix (•). The
set S2++ lies in the interior of S2+.
boundary of Sp+ comprises singular matrices of rank less than p, including the p× p zero
matrix; the interior comprises Sp++.
For illustration, let p = 2 and hence p(p+ 1)/2 = 3, so that any M ∈ S2 can be
represented as 
x y
y z

→ (x, y, z)T , (A.8)
where x, y and z correspond to the Cartesian coordinates in R3. Since |M| = xz − y2, the
matrix is in S2+ if x ≥ 0, z ≥ 0 and y2 ≤ xz, and also in S2++ if these inequalities are strict
(Boyd and Vandenberghe, 2004, p. 35). Sections of S2+ and S2++ are shown in Figure A.1.
A.3 Convex optimisation with constraints
The optimisation framework for relaxed design in this thesis applies general methods of con-
strained convex differentiable optimisation, which are discussed eg, in Bertsekas (2003),
Boyd and Vandenberghe (2004), Nocedal and Wright (2006), Fletcher (1987), Sundaram
(1996), Lasdon (2002) and Sukharev et al. (2005). The relevant applications of these meth-
ods are summarised in the current appendix.
We consider optimisation in the variable r = (r1, . . . , rn)T , which is a vector r ∈ Rn
with a fixed finite n ≥ 1. The objective function, f0(r), such that f0 : D0 → R, is convex
on its domain D0 ⊆ Rn. By our convention, f0(r) is minimised; its maximisation can be
handled by minimisation of −f0(r).
A. Mathematical background 104
In unconstrained optimisation, the solution r∗ could, in principle, be some vector any-
where in Rn, whereas in constrained optimisation, r∗ must belong to some set Ω, such that
Ω ⊂ Rn. (Thus, Ω = Rn, in unconstrained optimisation.) The set Ω is the problem’s feas-
ible set, which quantifies some physical, practical or other requirements to solutions. Any
r ∈ Rn such that r ∈ Ω is feasible and infeasible otherwise; thus Ω contains all the feasible
vectors r. The optimisation problem is feasible if Ω 6= ∅ and infeasible otherwise, that is,
can not have a solution. As illustrated later, Ω can be defined as some explicit set; or using
some constraint functions of r; or by a combination of the two methods.
The optimisation domain, D, such that D ⊆ Rn is a set such where every problem
function is defined upon. Thus, D is intersection of the domains of all the functions in the
given problem. We shall also require Ω ⊆ D.
An a convex optimisation problem Ω is convex and every problem function is convex
on its domain (which is a convex set, by Definition A.5). A general convex problem is the
following
Problem A.1 (Constrained convex minimisation).
minimize
Rn
f0(r) (A.9a)
subject to r ∈ Ω, (A.9b)
where n ∈ Z++ is fixed; f0 : D0 → R is convex on D0 ⊆ Rn; and Ω ⊆ D0 is a convex set.
(In this general formulation, we only require convexity of f0(r).)
Definition A.7 (Problem solution). A vector r∗ ∈ Rn is a minimiser and f0(r∗), the min-
imum, of f0(r) in Problem A.4 if r∗ ∈ Ω and f0(r∗) = inf{f0(r) | ∀r ∈ Ω}.
This definition implies that Ω 6= ∅ and that r∗ is a global, possibly non-unique, minimiser:
that is, f0(r∗) ≤ f0(r) for all r ∈ Ω. A local minimiser r† ∈ Ω is such that
f0(r
†) ≤ f0(r), ∀r s. t. ‖r − r
†‖ < ǫ, (A.10)
for some ǫ > 0; eg, Bertsekas (2003) Chapter 1.1. The possibility of local minima that are
not global poses many challenges in general optimisation. In convex problems, however,
any feasible vector satisfying (A.10) also satisfies Definition A.7. As we only consider
convex problems, the terms solution and minimiser shall imply global optimality.
A. Mathematical background 105
A constrained problem, even if feasible, need not have a solution. The following result,
which is sufficient but not necessary, ensures solution existence in some special cases of
Problem A.1.
Theorem A.1 (Weierstrass). If Ω is a nonempty and compact subset of Rn, and f0(r) is
continuous on Ω, then f0(r) achieves its infimum over Ω.
A.3.1 Lower bounds
The restriction of the type r ∈ S, where the set S such that S ⊂ Rn, is given explicitly is
called a set constraint. In the design problems, the set S that defines such constraints in this
thesis is of the following general form.
Definition A.8. The explicit constraint set A is defined as
A = {r ∈ Rn|rj ≥ aj or rj > aj}, (A.11)
where j = 1, . . . , n and each aj ≥ 0 is fixed.
To specify this A, the practitioner fixes n, and for each element j of vector r ∈ Rn
fixes the lower bound aj , by either the constraint rj ∈ [aj ,∞) or rj ∈ (aj ,∞), where
j = 1, . . . , n. The set A, which is nonempty, convex, but also unbounded and noncompact,
is exemplified by A = Rn+ or A = Rn++ specifically, for n = 2 we could have, say,
A = (1,∞)× [0,∞).
The follow problem, whose only constraint is r ∈ A, is directly to LOSS and some
CRIT design problems, and is also required for some results further in this appendix.
Problem A.2 (Convex differentiable minimisation over A).
minimize
Rn
f0(r) (A.12a)
subject to r ∈ A, (A.12b)
where n ∈ Z++ is fixed; f0 : D0 → R is convex and differentiable over an open set
D0 ⊆ R
n such that A ⊂ D0.
Since the feasible set Ω = A is not compact, the Weierstrass Theorem A.1 does not guar-
antee solution existence. The problem is convex by convexity of Ω and f0(r). Here, we
require differentiability of the objective function; the partial derivative of f0(r) with respect
to rj , where j = 1, . . . , n, is denoted as ∇jf0(r).
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Proposition A.2. If a solution to Problem A.2 exists, then some r∗ ∈ A is such a solution
iff
∇jf0(r
∗) ≥ 0, ∀j (A.13a)
∇jf0(r
∗) = 0 if r∗j > aj, (A.13b)
where j = 1, . . . , n.
An almost identical result is discussed in Bertsekas (2003) Chapter 2, for optimisation over
R
n subject to r ∈ Rn+. The following proof adapts the corresponding argument in Bertsekas
(2003), p. 195.
Proof By Proposition 2.1.2 of Bertsekas (2003), since f0(r) is convex and differentiable
over a convex set A, some r∗ ∈ A is a solution if and only if
∇f0(r
∗)T (r − r∗) ≥ 0, ∀r ∈ A, (A.14)
and thus
n∑
j=1
∇jf0(r
∗)(rj − r
∗
j ) ≥ 0, (A.15)
for every r ∈ A.
For simplicity, let n = 2 and thus A ⊂ R2 is defined with two real bounds, a1 and a2.
Suppose that r∗ = (r∗1, r∗2)T ∈ A is a solution. Define r = (r∗1 + 1, r∗2)T , which is in A,
and substitute it into (A.15) to obtain
∇1f0(r
∗) ≥ 0, (A.16)
since r − r∗ = (1, 0)T , for any r∗1 ≥ a1.
Now suppose that r∗1 > a1 and let ǫ = 0.5(r∗1 − a1) so that r∗1 − ǫ > a1. Define
r† = (r∗1 − ǫ, r
∗
2), which satisfies r† ∈ A, and substitute it into (A.15) to obtain
−ǫ∇1f0(r
∗) ≥ 0, (A.17)
since r† − r∗ = (−ǫ, 0)T , for any r∗1 > a1. As ǫ > 0, conditions (A.16) and (A.17) both
hold for r∗1 > a1 only if ∇1f0(r∗) = 0.
To prove the result for n = 2, we repeat the above argument for r∗2. The same argument
would prove this proposition for any fixed n ≥ 1. 
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This proof implies that ∇jf0(r∗) = 0 for every j such that rj ∈ (aj ,∞).
A.3.2 General problem
Problem A.3 (Convex minimisation).
minimize
R
n
f0(r) (A.18a)
subject to r ∈ S, (A.18b)
fk(r) ≤ 0, k = 1, . . . ,m, (A.18c)
where n ∈ Z++ and m ∈ Z++ are fixed; each fk : Dk → R, for k = 0, . . . ,m, is convex
on Dk ⊆ R
n; the optimisation domain D =
⋂m
k=0Dk is an open set; the set S 6= ∅ is
convex and satisfies S ⊆ D.
The expression (A.18c) introduces m inequality constraints, each defined by the functional
inequality fk(r) ≤ 0, where k = 1, . . . ,m. The form fk(r) ≤ 0, standard in the literature
(eg, Luenberger and Ye (2008)), easily obtains from other specifications: eg, f˜k(r) ≥ c,
where c ∈ R, is equivalent to−f˜k(r)+ c ≤ 0, so that setting fk(r) = −f˜k(r)+ c produces
the standard form.
The set of all vectors r ∈ Rn that satisfy constraint k is denoted as
Ωk = {r ∈ Dk|fk(r) ≤ 0} (k = 1, . . . ,m), (A.19)
which is convex by convexity of fk(r). The feasible set for the problem is
Ω = S ∩ Ω1 ∩ . . . ∩ Ωm, (A.20)
which is convex as the intersection of convex sets. Furthermore, since S ⊆ D, every
problem function is defined everywhere in Ω.
Definition A.9. Problem A.3 is strictly feasible if there is r ∈ Ω such that fk(r) ≤ 0 for
all k, and fk(r) < 0 for every nonlinear fk(r), where k = 1, . . . ,m.
This is a Slater’s constraint qualification for convex constrained problems; eg, Lasdon
(2002), Chapter 1 and Boyd and Vandenberghe (2004) Chapter 5. Notably, if constraint
k is linear then fk(r) = 0 is admissible, and any problem with linear inequality constraints
only is strictly feasible.
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Solution to Problem A.3 can be characterised via the Lagrangian framework of convex
optimisation. First, the Lagrangian function L : D × Rm+ → R is defined as
L(r,λ) = f0(r) +
m∑
k=1
λkfk(r) (r ∈ D, λ ∈ R
m
+ ), (A.21)
where f0, . . . , fm, all defined onD, are from Problem A.3. The vector λ = (λ1, . . . , λm)T ∈
R
m
+ contains Lagrange multipliers, with the multiplier λk ≥ 0 assigned to the inequality
constraint fk(r) ≤ 0, where k = 1, . . . ,m.
Definition A.10. A point (r∗,λ∗) such that r∗ ∈ S and λ∗ ∈ Rm+ is a saddle point for
L(r,λ) over S if
L(r∗,λ) ≤ L(r∗,λ∗) ≤ L(r,λ∗), (A.22)
for all r ∈ S and all λ ∈ Rm+ .
(Lasdon (2002), p. 83; Bertsekas et al. (2003), p. 131). At a saddle point, the Lagrangian
is therefore simultaneously minimised in r ∈ S and maximised in λ ∈ Rm+ . Given a fixed
λ∗, the function L(r,λ∗) is convex over S, whereas for a fixed r∗, the function L(r∗,λ)
is convex as a linear function of λ over Rm+ . Thus, any point satisfying Definition A.10 is
‘global’, but not necessarily unique. (Some further properties of λ are discussed in the next
section.)
Theorem A.2. For some r∗ ∈ S and λ∗ ∈ Rm+ the point (r∗,λ∗) is a saddle point of
L(r,λ) over S if and only if:
(i) r∗ minimises L(r,λ∗) over S;
(ii) fk(r∗) ≤ 0, for k = 1, . . . ,m;
(iii) λ∗kfk(r∗) = 0, for k = 1, . . . ,m.
(Stated from Lasdon (2002), Chapter 1.3, which also contains a proof.)
The solution to Problem A.3 is characterised by the following result stated from The-
orem 3 in Lasdon (2002), Chapter 1.3, which also utilises Theorem A.2.
Theorem A.3. If Problem A.3 be strictly feasible then the following hold
(i) If r∗ ∈ S is a feasible minimiser in Problem A.3 then there exit Lagrange multipliers
λ∗ ∈ Rm+ such that (r∗,λ∗) is a saddle point of L(r,λ) over S;
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(ii) Conversely, if r∗ ∈ S and λ∗ ∈ Rm+ are such that (r∗,λ∗) is a saddle point of L(r,λ),
then r∗ is a feasible minimiser in Problem A.3.
This result is flexible as it only requires convexity of Problem A.3; however, solution exist-
ence is not guaranteed. If r∗ exists, it must belong to Ω, but need not be strictly feasible.
A.3.3 Differentiable problem
We now additionally assume that the set constraint (A.18b) is specified with set A, charac-
terised by Definition A.8, and that every problem function in Problem A.3 is differentiable.
Thus, the following problem is applicable to every COST and CRIT problem of relaxed
design in this thesis:
Problem A.4 (Convex differentiable minimisation over A).
minimize
Rn
f0(r) (A.23a)
subject to r ∈ A, (A.23b)
fk(r) ≤ 0, k = 1, . . . ,m, (A.23c)
where n ∈ Z++ and m ∈ Z++ are fixed; each fk : Dk → R, for k = 0, . . . ,m, is convex
and differentiable on Dk ⊆ Rn; and the optimisation domain D =
⋂m
k=0Dk is an open set;
the set A satisfies Definition A.8 and also A ⊆ D.
The feasible set is now
Ω = A ∩Ω1 ∩ . . . ∩ Ωm, (A.24)
whereas the Lagrangian L : D × Rm+ → R is defined as
L(r,λ) = f0(r) +
m∑
k=1
λkfk(r) (r ∈ D, λ ∈ R
m
+ ), (A.25)
identically to (A.21). The differentiability of f0, . . . , fm along with the special struc-
ture of A allows us to use the following adaptation of Karush-Kuhn-Tucker Theorem (eg,
Sundaram (1996), Lasdon (2002) or Boyd and Vandenberghe (2004)) to Problem A.4):
Theorem A.4 (Karush-Kuhn-Tucker). Suppose that Problem A.4 is strictly feasible and the
feasible set Ω is compact. Then, a global minimiser in this problem exists. Some r∗ ∈ Ω is
such a minimiser if and only if there exist Lagrange multipliers λ∗ = (λ∗1, . . . , λ∗m) ∈ Rm+
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such that
∇jL(r
∗,λ∗) ≥ 0, j = 1, . . . , n (A.26a)
∇jL(r
∗,λ∗) = 0, if r∗j > aj; (A.26b)
λ∗kfk(r
∗) = 0, k = 1, . . . ,m, (A.26c)
where ∇jL(r,λ) is the derivative of (A.25) with respect to rj .
The justification of this result is as follows. Since Ω is nonempty and compact, whereas
f0(r) is continuous, a solution r∗ exists by the Weierstrass Theorem A.1. Also, r∗ is glob-
ally optimal by problem convexity. Theorem A.3, asserts that r∗ and λ∗ solve Problem A.4
if and only if (r∗,λ∗) is a saddle point of the Lagrangian function (A.25) over A. Thus,
Definition A.10 and Theorem A.2 imply that r∗ ∈ Ω, where Ω is defined in (A.24). Fur-
thermore, Theorem A.2 also implies that r∗ is a global solution to
minimize
Rn
L(r,λ∗) s. t. r ∈ A, (A.27)
where the objective function L : D → R is the Lagrangian (A.25) with a fixed λ∗. This
minimisation problem is just Problem A.2, whose solution, r∗ ∈ A, however, must exist.
Thus, Proposition A.2 implies the optimality conditions (A.26a) and (A.26b).
Condition (A.26c), also implied by Theorem A.2, is called complementary slackness
and together with λ∗ ∈ Rm+ asserts that λ∗k and fk(r∗) cannot both be positive for any
k = 1, . . . ,m. One implication is of this is that L(r∗,λ∗) = f0(r∗), since all the terms
λ∗kfk(r
∗) in (A.25) vanish. Another implication follows from the following classification
of the constraints:
Definition A.11. Let r∗ ∈ Ω and λ∗ ∈ Rm+ solve Problem A.4 specified with the inequality
constraints fk(r) ≤ 0 where k = 1, . . . ,m. A constraint fk(r∗) is called
• inactive if fk(r∗) < 0 and λ∗k = 0;
• weakly active if fk(r∗) = 0 and λ∗k = 0;
• strongly active if fk(r∗) = 0 and λ∗k > 0.
A graphical interpretation of these three types is given in Fletcher (1987), p. 201. (Note that
since r∗ is feasible, no constraint can be violated, that is, fk(r∗) > 0 cannot hold.) Inactive
constraints cannot influence the solution r∗, and if identifiable before optimisation, can be
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safely discarded from the problem; Bertsekas, 2003, Chapter 3.3. Technically, a weakly
active constraint might be also omitted; however, any tightening of the constraint would
make it active. Only strongly active constraints are absolutely essential.
A practical interpretation of optimal Lagrange multipliers for active constraints is the
larger the value of λ∗k, the more sensitive is the optimal value f0(r∗) to tightening or loosen-
ing of the constraints; Boyd and Vandenberghe (2004), Chapter 5.6 provides a formal char-
acterisation of such sensitivity.
Proposition A.3. The vector of optimal Lagrange multipliers λ∗ ∈ Rm+ in a constrained
optimisation problem is
(i) bounded if the problem is convex (Bertsekas (2003), Chapter 5);
(ii) unique if the gradients of the strongly active constraints at the solution are linearly
independent (Nocedal and Wright (2006), Chapter 12.3).
B. ENZYME KINETICS SUPPLEMENT
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B.1 Henri-Michaelis-Menten model
This section provides some background on the Henri-Michaelis-Menten model of enzyme
kinetics. This model was proposed in Menten and Michaelis (1913), who extensively drew
on the earlier work by Henri (1903). The discussion in this section is based on Segel (1993),
which is a standard book on enzyme kinetics.
B.1.1 Enzyme kinetics
A drug metabolised by a particular liver enzyme is called a substrate for the enzyme. Sup-
pose have that 100% of a substrate is metabolised by a single enzyme. Then, the metabolic
reaction proceeds according to
E + S
k1
⇋
k−1
E S
k2→ E +M, (B.1)
where E, S, ES and M stand for the enzyme, substrate, enzyme-substrate complex and the
metabolite, respectively; and the positive constants k1, k−1 and k2 characterise the rates of
the reaction steps (Segel, 1993, p. 7). The complex ES is formed from free enzyme and
substrate in
E + S
k1→ ES. (B.2)
In some cases, the reverse step
E + S
k−1
←ES (B.3)
occurs next, whereby the enzyme and substrate are released chemically unchanged. In the
other cases, the forward step
ES
k2→ E +M (B.4)
occurs, in which the enzyme is released unchanged and the substrate is irreversibly conver-
ted into its metabolite, which has no further chemical interactions. This reaction is illus-
trated in Figure B.1.
We use the chemical notation, such as [ES]t and [E]t, to denote the concentration of
some chemical species in a reaction as a function of the reaction time t ≥ 0. Each such
function is the reaction progress curve for the given reactant. The progress curves for the
reactants in (B.1) are described by the following differential and mass balance equations
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t = 0 t ∈ (0, tstop) t = tstop
E + S ⇋ E S → E +M
Fig. B.1: Metabolic reaction is started at t = 0 by adding 4 units () of enzyme into a vessel with
30 units (•) of substrate. At time t ≥ 0 metabolite (•) results from unbinding of some ES
complexes. The reaction is terminated at some tmax by adding a stopping agent.
(Segel, 1993, p. 28):
d[ES]t
dt
=k1[E]t[S]t − (k−1 + k2)[ES]t (B.5a)
d[E]t
dt
=− k1[E]t[S]t + (k−1 + k2)[ES]t (B.5b)
d[S]t
dt
=k−1[ES]t − k1[E]t[S]t (B.5c)
d[M ]t
dt
=k2[ES]t (B.5d)
[E0] =[E]t + [ES]t (B.5e)
[S0] =[S]t + [ES]t + [M ]t, (B.5f)
with the initial conditions [E]0 = [E0], [ES]0 = 0, [S]0 = [S0] and [M ]0 = 0, where
[E0] > 0 and [S0] > 0 are the known enzyme and substrate amounts, respectively, at t = 0.
Equation (B.5e) implies that the total enzyme concentration remains constant. Equation
(B.5f) implies that the initial substrate is split between the free substrate, the ES complex
and the metabolite.
Figure B.2 plots the progress curves obtained from (B.5) under the assumption of k1 =
1, k−1 = 2, k2 = 0.5, [E0] = 4 and [S0] = 30. (Since no analytical solutions of (B.5)
are available, these curves were obtained numerically, using the MatLab numerical solver
for differential equations.) Figure B.2 shows a fast growth in [ES]t soon after t = 0, after
which [ES]t changes little over a prolonged period. This period corresponds to the reaction
B. Enzyme kinetics supplement 115
0 5 10 15 20 25
0
5
10
15
20
25
30
T ime
A
m
ou
n
t
Fig. B.2: Progress curves for a metabolic reaction: concentration of metabolite ( ); substrate
( ); enzyme ( ); enzyme/substrate complex (••).
steady state, during which
d[ES]t
dt
≈ 0, −
d[S]t
dt
≈
d[M ]t
dt
, (B.6)
ie, almost all of the metabolite formation is accounted for by the substrate depletion.
B.1.2 Model definition
The overall rate, v(t), of reaction (B.1) is defined as the rate of the metabolite formation:
v(t) =
d[M ]t
dt
= k2[ES]t (t ≥ 0), (B.7)
which is proportional to [ES]t. The Henri-Michaelis-Menten model characterises thisv(t)
under the assumption of a steady state.
This model is derived as follows. The assumption d[ES]t/dt = 0 at a steady state
implies
k1[E]t[S]t = (k−1 + k2)[ES]t, (B.8)
from which we define
K =
[E]t[S]t
[ES]t
=
k−1 + k2
k1
, (B.9)
which is a positive constant. Thus, [ES]t = [E]t[S]t/K and [E0] = [E]t + [E]t[S]t/K.
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Fig. B.3: Initial concentrations [S0] ∈ {1, 8.33, 30}. Left panel: v(t) from (B.12); right panel:
corresponding concentration of the metabolite.
Hence, (B.7) can be written as
v(t)
[E0]
=
k2[E]t[S]t/K
[E]t + [E]t[S]t/K
(t ≥ 0). (B.10)
Denote V = k2[E0] > 0, which is constant as the initial enzyme concentration [E0] is a
physiological constant. Thus, (B.10) becomes
v(t) =
V [E]t[S]t/K
[E]t + [E]t[S]t/K
(t ≥ 0), (B.11)
which simplifies to
v(t) =
V [S]t
K + [S]t
(t ≥ 0). (B.12)
The last expression is the version of the Henri-Michaelis-Menten model that depends on the
reaction time and on the initial substrate concentration [S0].
In therapeutic applications, the enzyme concentration [E0] is typically much smaller
than [S0]. Also, a steady state is achieved very rapidly, sometimes in a matter of milli-
seconds. We now assume that k1 = 1 and k−1 = 2, as before, while [E0] = 0.004. Fig-
ure B.3 plots the corresponding v(t) modelled by (B.12) as a function of time for different
initial values [S0].
Figure B.4 zooms in to the very early period of the metabolic reaction displayed in Fig-
ure B.3. A steady state is rapidly achieved, during which the reaction rate is approximately
constant over a period of time. At this period, the rate is mainly determined by the initial
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Fig. B.4: Early time period: Initial concentrations S0 ∈ {1, 8.33, 30}. Left panel: v(t) from (B.12);
right panel: corresponding concentration of the metabolite.
[S0]. In this case, the Henri-Michaelis-Menten model is defined as
v ≈
V [S0]
K + [S0]
, (B.13)
for some ‘early’ time t, when the substrate depletion is negligible. The response in (B.13)
is called the initial metabolic rate, and the explanatory factor, [S0], the initial substrate
concentration. This version of the Henri-Michaelis-Menten model is assumed in the phar-
maceutical experiments considered in this thesis.
B.2 Extrapolation of experimental costs
The design examples in this thesis are based on enzyme kinetics studies with the Henri-
Michaelis-Menten model (ηHM ) and on enzyme inhibition studies with the competitive
inhibition model. The costs assumed in these examples were extrapolated based on an
experiment described in Volkov et al. (2008). This paper was co-written with co-authors
from Pfizer Global R&D, Sandwich, UK.
CYP3A4/Midazolam experiment The paper considered optimal design of a hypothetical
enzyme kinetics study with the substrate Midazolam and the enzyme CYP3A4. The goal
was to design an experiment for parameter estimation of ηHM , with the optimal design
sought under the local D-criterion and realistic experimental costs. The hypothetical rich
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design for this study was assumed as

0 0.3 0.4 1 1.33 3 4 10 13.3 30 40 100 133 300 400
4 4 4 4 4 4 4 4 4 4 4 4 4 4 4

 , (B.14)
with n = 15 substrate concentrations and N = 60 total replications. This design is typical
of standard designs used in enzyme kinetics. However, only the first eleven xj in this design
would be used in an actual experiment with CYP3A4/Midazolam. The reason is that the
model ηHM for this enzyme and substrate is usually assumed for up to xmax = 50.
The following cost was assumed:
φ(̺) = v11
Tr + v2x
Tr + v3x
Tr, (B.15)
where v1 > 0 is the fixed cost per observation; v2 > 0 the price of incubation reagents per
unit of x; and v3 > 0 the price of Midazolam itself per unit of x. Realistic cost estimates
for this experiment were provided by the co-authors from Pfizer UK. The total cost for this
design was estimated as £216, including £88 for the total fixed costs, independent from xj .
The total variable costs, dependent on x, included £23 for incubation reagents and £105
for Midazolam itself. The substrate quantity required by (B.14) is A = 41Tx ≈ 4145.3.
Correspondingly, we compute
v1 = 88/60 ≈ 1.47, v2 = 23/4145.3 ≈ 0.0056, v3 = 105/4145.3 ≈ 0.0253,
(B.16)
in pounds sterling.
CYP2C19/S-Mephenytoin experiment We next extrapolate the costs of the CYP2C19/S-
Mephenytoin enzyme kinetics study considered in Chapter 3. We assume that the cost
structure is similar to that of CYP3A4/Midazolam experiment, except for the use of s-
Mephenytoin instead of Midazolam. Thus, we fix v1 and v2 as in (B.16). The unit price
of s-Mephenytoin was extrapolated based on the UK product catalogue of SigmaAldrich,
a widely used supplier of reagents for pharmaceutical research. The catalogue is available at
http://www.sigmaaldrich.com/catalog/. Both Midazolam and s-Mephenytoin
were available in the same quantity. The price ratio per mg of Midazolam to s-Mephenytoin
was 1 : 2.4259, as of 10 April 2014. Correspondingly, the assumed unit price of s-
Mephenytoin was 2.4259v3 ≈ £0.0614. The extrapolated cost function for CYP2C19/S-
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Mephenytoin experiment was
1.471T r + (0.0056 + 0.0614)xTr ≈ 1.471T r + 0.0670xTr. (B.17)
To ensure robust comparison of designs, the cost function in Example 3.4 was assumed as
φ(̺) = 1.471Tr + 0.0441xTr, (B.18)
with v2 about 1.5 times less that in (B.17). The rich design in Example 3.4 was based on an
actual experiment, with CYP2C19/S-Mephenytoin, reported in Di-Marco et al. (2007). That
rich design had N = 20 and cost £122.67, which is comparable to £216, the empirical cost
of the CYP3A4/Midazolam experiment.
Enzyme inhibition experiment: CYP2D6/Dextrometorphan + Sertraline The costs of the
enzyme inhibition study in Section 5.1 were extrapolated similarly, using http://www.
sigmaaldrich.com/catalog/. The prices for Midazolam, Dextrometorphan and
Sertraline were related as 1 : 0.3943 : 0.2413, as of 10 April 2014. The extrapolated
unit prices were £0.01 for Dextrometorphan and £0.0061 for Sertraline. The incubation
reagents were assumed to be dependent on substrate concentrations only. The following
extrapolated φ(̺) was assumed
φ(r) = 1.471Tr + 0.0156xTr + 0.0061uTr, (B.19)
which evaluates the cost the rich design, with N = 240, in Section 5.1, as £394.93, which
is comparable to the cost of (B.14).
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